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Abstract
This work aimed at understanding the interactions of 1) three physiologically relevant
transition metal ions copper(II), cobalt(II) and manganese(II) with five tri- or tetra-dentate metal
chelators (ligand or L) and 2) the resulting ML complexes with two known metalloenzyme
inhibitors, 8-hydroxyquinoline (8-HQ) and acetohydroxamic acid (AHA). The ultimate goal of
the work was to identify ligands that can form enzyme active site M2+ structural mimetics
capable of interacting with metalloenzyme active site inhibitors. The ligands studied were N-(2(1-methylimidazolyl)methyl)iminodiacetic acid (DA2Im), nitrilotriacetic acid (NTA), tris(2aminoethyl)amine (TREN), tris(2-pyridylmethyl)amine (TPA), and bis(2-picolyl)amine (BPA)
and they were chosen to mimic the coordination environment for the common enzyme active site
transition metal ions. Isothermal titration calorimetry (ITC), UV-Vis absorbance spectroscopy
and computational chemistry were used for the study. The appropriate ligand to form the copper
active site structural mimetic was identified as bis(2-picolyl)amine (BPA) as BPA was found to
bind Cu2+ strongly forming a 1:1 Cu(BPA) binary complex. Upon addition of 8-HQ, Cu(BPA)
formed a Cu(BPA)(8-HQ) ternary complex. Cu(TREN) and Cu(TPA) however did not form
CuL(8-HQ) ternary complex but rather had the TREN or TPA displaced by 8-HQ, yielding the
Cu(8-HQ)2 complex. Results from this work helped us better understand the binding reactivity of
Cu2+, Co2+ and Mn2+ ions with the small molecule ligands and the enzyme active site inhibitors.
The experiments also helped us estimate the energetic contribution of the active site metal ion to
enzyme inhibitor binding. Results of this study will be useful to developing new therapeutics
targeting metalloenzymes involved in diseases such as cancer.
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Chapter 1: Introduction
1.1. First Row Transition Metal ion (II)
Although metals only account for 3% by mass of the human body, they play a
disproportionately integral role in the body’s function.1 Among the physiological metal ions are
the first-row transition metals, which are present at the enzyme active sites – and subsequently
are key to the catalytic functions of a group of enzymes termed metalloenzymes.2
Metalloenzymes are involved in multiple physiological processes that may include the
biosynthesis of DNA, biosynthesis of certain amino acids, breakdown of metabolites, etc. The
exact nature of the association of the metal ion with the active site varies in metalloenzymes. In
some metalloenzymes, the metal ion is permanently attached to the active site while in others the
metal ion is a labile part of a coenzyme. 3
To ensure that good inhibitors for metalloenzymes are developed to treat various deases, it is
important to be aware of the basic characteristics of various transition metal ion groups and their
roles in enzymes. The first-row transition metal ions in the +2 oxidation state a common species
in a variety of metalloenzymes. For instance, manganese to zinc act as metalloenzyme cofactors
in the cells of almost all living beings. Moreover, it is because of the essential nature of these
first-row late d-block transition metal ions, the human innate immune system has developed their
immunity to invading microbial pathogens in a process termed "nutritional immunity." Emerging
evidence suggests that Mn, Fe, and Zn are withheld from the pathogen in classically defined
nutritional immunity, while Cu is used to kill invading microorganisms.4 But successful
9

pathogens have the tendency to develop a mechanism for the adaptive response that can be used
to mitigate and reduce the effects of host control of transition metal bioavailability.
Enzymes, which are mostly proteins and act as the catalysts in the living world, have been
designed by nature to catalyze a variety of reactions under controlled and exquisitely selective
conditions of temperature, pressure, and pH. This attribute of enzymes have been harnessed to
produce desirable results for industrial and other purposes.5 For the purpose of this research, we
have focused on Cu2+, Co2+, and Mn2+, some of the main first-row transition metal ions that can
bind to many enzymes in the living cells. The biological roles of these metals are discussed
below.
1.2. Copper Ion (II)
Copper (Cu, either as Cu+ or Cu2+) is an essential trace element that acts as a cofactor
important for a wide variety of physiological processes such as peptide amidation,
neurotransmitter biosynthesis, cellular respiration, pigment formation, nervous system
development and connective tissue strengthening.6 Cu also contributes to the function of the
central nervous system (CNS) and is found in multiple regions of the brain including the basal
ganglia, hippocampus, and cerebellum.6 It is found in the cell bodies of several specific types of
neurons as well as in the synaptic cleft.6 Therefore, Cu plays an integral role in the development
and nourishment of neurons and other brain cells. Multiple CNS enzymes depend on Cu for
activity and they include tyrosinase, peptidyl lysine-amidating mono-oxygenase, Cu/Zn
superoxide dismutase, caeruloplasmin, hephaestin, dopamine-hydroxylase, and cytochrome c
oxidase.6
10

In light of its essential role in various physiological processes, copper overloading or
deficiency could lead to disease states. For example, Menkes disease and amyotrophic lateral
sclerosis (ALS) both are caused by copper deficiency while Wilson’s disease is a result of copper
overloading. Additionally, physiological accumulation of copper is also characteristic of multiple
other diseases such as Alzheimer’s disease, Huntington’s disease, Parkinson’s disease, prion
disease, and occipital horn syndrome, although it is not clear whether copper accumulation is the
direct cause or consequence of the disease. 7,8
Homeostatic imbalances of copper can be caused by excessive intake or by genetic
abnormality that can cause copper deficiency or abnormal accumulation.9 For healthy adults, the
optimal daily dietary intake of copper is no less than 0.9 mg and no more than 10 mg, preferably
within 1–2 mg. 7,10 Low concentrations of copper can inhibit cell growth while abnormal storage
or piling of copper in the liver can cause long term liver damage. 11,5 For example, in Wilson’s
disease, copper binding with ATP7B, an ATPase, is dysfunctional, which prevents copper
incorporation into caeruloplasmin, a copper binding protein in plasma, therefore leading to an
abnormally high accumulation of copper in the liver. If not corrected, this copper accumulation
will cause permanent liver damage.9 Similarly, Menkes disease is caused by a X-linked recessive
mutation in an ATPase, ATP7A, responsible for transporting copper across cell membrane for
copper uptake from the blood, therefore leading to copper deficiency in the cell.9 Abnormal
accumulation of copper in neurological disorders have also been shown to be caused by
abnormal copper transport and aberrant copper-protein interactions. One of the consequences of
such abnormality could be oxidative stress that copper exerts on cells and tissues as copper is
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known to increase oxidative stress that could cause mitochondrial damage, DNA breakage, and
neuronal injury.9
The toxicity of copper in part has to do with the tendency of Cu to participate in Fentonlike reactions.12 Such reactions likely exist in most forms of copper-induced cell damage. The
Cu+ ion induces the formation of hydroxyl radical (HO•) via its reaction with hydrogen peroxide
that is a product of metabolism (Eq. (1)). It can also generate superoxide anion (O2•−) in reaction
with molecular oxygen (Eq. (2)), which is the most toxicity-generating mechanism.
+
2+
Cu + H2O2 → Cu + HO• + HO−

+

Eq. (1)

2+

Cu + O2 ⇄ Cu + O2•−

Eq. (2)

Additionally, the superoxide anion (O2•−) generated in the second reaction will react with H2O2,
generating HO• (Eq. (3)) in the Haber and Weiss reaction.13
O2•− + H2O2 → O2 + HO• + HO−

Eq. (3)

The HO• free radical generated in the first mechanism is highly reactive, capable of oxidizing
every type of biological molecules including lipids, proteins and nucleic acids. Oxidation of
these molecules will lead to loss of function.12

Even trace amount of copper can impact the proper neurodevelopment and neurological
function.7 Our body has in place an elaborate mechanism to avoid the exposure of cells to free
copper. Copper is therefore suggested to be used as one of the selective targets for treatments of
12

neurological diseases through control of copper levels using metal chelators. 13 Metal chelators
have been shown to be effective in bringing down copper concentration in the human blood such
as in the case of copper toxicity.4 The use of metal chelators also helps treating cancer, especially
in treating colon cancer.4
To avoid the exposure of cells to free copper, multiple copper binding and transport
proteins are used. To begin with, Cu is absorbed in the stomach and intestine in complex with
amino acids (such as histidine) or short peptides. These Cu complexes enter the blood stream
where Cu becomes bound to the serum albumin and transcuprein. Copper is then taken up and
deposited into the liver where it binds to the glycoprotein caeruloplasmin, specifically at 6 - 7
moles of copper per mole of protein with very high affinity. Cu-bound caeruloplasmin is later
released into the circulation where Cu2+ is reduced to Cu+ as a result of redox reactions with
components such as low density lipoprotein (LDL).14,15 The majority of the circulating Cu
exiting the liver is bound to caeruloplasmin with the remaining trace amount of Cu transported
through the plasma protein albumin and the amino acid histidine. Careuloplasmin-bound Cu+ is
then taken up by peripheral cells through multiple transmembrane transporters including Ctr1
and Ctr3. This likely occurs via careuloplasmin degradation to release the bound Cu ion due to
its high affinity the very tight binding. This means that cells invest energy to break down the
copper-binding protein to avoid exposure of copper to other copper-binding molecules thereby
avoiding toxicity.14
In light of the importance of copper in physiological functions, much research has been
done to understand the involvement of copper in human physiology and the processes that
impact the circulation of copper in the body. According to recent research, copper deposits is
13

also integral to the generation of inflammations and tumor growth.16 The concentration of
caeruloplasmin and other copper-binding components such as transcuprein is significantly higher
in patients with such conditions than in healthy subjects. Tumor cells are found to readily take up
copper from caeruloplasmin fractions of the plasma.11,17 It turns out that copper is a vital cofactor
for tumor angiogenesis thus is crucial for tumor growth and metastasis. Therefore, any form of
copper deposits in the body can be dangerous. Research has also shown that patients diagnosed
with cancer of the breast, prostate, colon, lung, and brain have higher concentrations of copper in
their blood stream. This makes high concentrations of copper ion a risk factor as it predisposes a
person to cancer.16
All organisms have developed sophisticated copper homeostasis and resistance systems to
maintain the normal cellular copper supply to essential cuproenzymes while detoxifying excess
copper. Recent work suggests that host- derived copper is used as an antibacterial weapon; thus
both host and bacterial pathogens actively engage cellular processes to manipulate copper levels
at key sites during bacterial infections. Upon entering cells, copper ions bind to different sites
such as bacterial metallothionein (MymT) in M. tuberculosis, cytochrome oxidase, superoxide
dismutase and copper chaperones that operate in both the periplasm and the cytoplasm,
multicopper oxidases (MCOs) that oxidize Cu+ to less toxic Cu2+ to avoid its oxidative damage to
proteins, DNA and cellular membranes.18
To understand the interaction of Cu with these biological Cu binding molecules, the interaction
of copper with ligands has been extensively studied for decades. Copper in biological systems
can exist in either the reduced Cu+ (3d10) state or the oxidized Cu2+ (3d9) state. The reduction
potential of +150 mV for Cu2+/ Cu+ makes Cu+ as the major oxidation state of copper in the
14

reducing environment of the cytosol (approximately −220 mV). Copper(I) is a soft acid while
Cu2+ is a borderline acid; as such, first coordination shell ligands in copper-sensing or transporting proteins are formed primarily by cysteine, methionine, and histidine residues.
Copper(I) is relatively unique in biology in that it adopts thermodynamically stable complexes
characterized with a low coordination number (n) of 2−4. In contrast, Cu2+ forms the higher
number of coordination bonds in complexes with an n of 4−6. The resulting complexes have the
tendency to exchange oxidation state and thus the coordination complexes within the biological
systems.18,19
Copper(II) ligands complexes with coordination number of 4 - 6 has many kinds of
irregular coordination geometries.20 This phenomenon is caused by the “plasticity effect” as a
result of the Jahn-Teller theorem regarding the structures of transition metal ion-ligand
complexes which causes distortion from symmetrical octahedral geometries. The John-Taller
theorem states that "A nonlinear polyatomic system in a spatially degenerate electronic state
distorts spontaneously in such a way that the degeneracy is lifted and a new equilibrium structure
of lower symmetry is attained".20 This means that"... stability and degeneracy are not possible
simultaneously unless the molecule is a linear one ..."20
Based on the theorem, other subtle ligand factors such as ligand constraints, steric hindrance
and the strength of the ligands’ donor atoms will also affect the geometry of the coordination
polyhedron around Cu2+.20 For example, two closely related imidazole thioether compounds with
a N2S2 donor set form complexes of different geometry (pseudoctahedral or trigonal
bipyramidal) for the difference of a single methyl group. One of the compounds also formed two
different geometry (pseudoctahedral or trigonal bipyramidal) around Cu2+ depending on the
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anion identity, further highlighting the effect of ligand factors.21 Given its d9 electronic
configuration (t62g e3g), the Jahn–Teller effect is prominent for octahedral Cu2+ complexes22
because an odd number of electrons occupy the two high energy eg orbitals. Distorting the
geometry has the effect of lowering the energy of the system, although to a small extent,
breaking the degeneracy of the eg set, reducing the symmetry, and leading to occupations at
lower energy orbitals.23
An example of a cuproenzyme is mushroom tyrosinase (TY), a rate-limiting enzyme
controlling the production of melanin from tyrosine. This enzyme has a dinuclear Cu2+ which are
oxidized in a controlled manner during the production of melanin. As shown in (Figure 1.2), the
two active-site Cu2+ ions are bound by six histidine residues. TY converts l-tyrosine to l-DOPA
(L-3,4-dihydroxyphenylalanine) and subsequently l-DOPA to dopaquinone (Figure 1.2).
Dopaquinone eventually forms melanin. Inhibition of TY therefore decreases melanin production
and even leads to skin whitening. Developing TY inhibitors for inclusion in lotions is therefore
gaining popularity in cosmetic industry. 24
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Figure 1.2 Reaction catalyzed by and active sites of the metalloenzyme studied TY (2Y9W).
Residues involved in ligating the metal ion are explicitly shown. 24

Copper ion has been used as spectroscopic probe for other metalloenzyme such as
carboxypeptidase A (CPA), a zinc (d10) metalloenzyme. Such metal substitution strategies were
introduced by Yamamura & Kaiser (1976). CPA exhibits peptidase, esterase, and thioester
hydrolysis activities.25 When Cu2+ substitutes the Zn2+ in CPA, it yields [Cu]-CPA that no longer
exhibits the peptidase and esterase activities but retains the thioester hydrolysis activity, and the
unpaired electron in Cu(II) allows for more spectroscopic methods to be used.26 Spectroscopic
studies have shown that Cu2+ coordination in CPA causes distortion of the N2O2 tetrahedral
geometry, explaining the loss of the peptidase and esterase activities, but not the ability to bind
CPA inhibitors.26
Copper ligand complexes have also been developed for diseases involving copper
overloading. The pharmacological activities of such metal ligand complexes are dependent on
the nature of the ligands and the metal ions. Among complexes of the first-row transition metal
ions with a given ligand, copper complexes often have the highest binding efficiency, will be
further discussed in the results section.

1.3. Cobalt Ion (II)
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Cobalt exists primarily as Co2+ and Co3+ under biological conditions. Co2+, the only
commonly-occurring d7 metal ion, is paramagnetic in both low or high spin, and can adopt either
tetrahedral or octahedral geometry. Co3+, on the other hand, exhibits predominantly octahedral
geometry, and therefore in low spin configuration is diamagnetic. Cobalt complexes have a
variety of reported applications, ranging from the control of radical polymerisation to the
catalysis of hydrogen-generation from water. There is also much current interest in the
interaction of cobalt complexes with biological systems, in understanding their antioxidant
behavior, anticancer activity, and potential uses as chaperones of cytotoxic agents.27

Cobalt is less frequently encountered in metalloproteins than the other first-row transition
metals such as manganese, iron, copper and zinc. However, as vitamin B12’s central metal, it is
an important cofactor in the vitamin-B12-dependent enzymes involved in DNA synthesis, fatty
acid and amino acid metabolism.28,29 Cobalt plays a key role in the normal function of the brain
and nervous system, and the formation of red blood cells. In B12, the cobalt ion is found in the
center of the tetrapyrrole ring, bonding to its four nitrogen atoms and a dimethylbenzimidazole
group at the 5th coordination site. The 6th coordination site is occupied by one of four possible
groups, a cyano group (-CN), a hydroxyl group (-OH), a methyl group (CH3) or a 5’deoxyadenosyl group with the latter two ligands coordinated through a Co-Csp3 bond.30

In addition to its essential role as part of enzyme cofactor B12, cobalt is often used as a
spectroscopically active substitute for Zn(II) in enzymes.31-35 Cobalt (II) has been extensively
used as a spectroscopic probe in many proteins, mainly replacing zinc, but also substituting for
iron, manganese and copper ions.31 The relatively short electronic relaxation times of high-spin
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cobalt(II) makes this ion suitable as a paramagnetic probe for NMR spectroscopy. Metal binding
sites in enzymes that contain catalytically active Zn(II) generally yield high-spin S = 3/2 Co(II)
ions when substituted with cobalt, and these provide EPR spectra rich in information. The
applicability of cobalt as a spectroscopic probe for the structure and function of zinc
metalloenzyme active site is dependent on how close cobalt mirrors the properties of zinc.36 Co2+
ions form 3- or 4-coordination bonds at enzyme active site with supporting groups similar to
those for enzyme active site zinc. They include all O ligand groups (Asp/Glu), mixed O and N
groups (Asp/Glu and His), mixed N and S groups (His and Cys) and all N groups (His).30
However, the difference in their d orbital electron configuration (d7 Co2+ and d10 Zn2+) means
that there are likely differences in the structure and affinity of these two metal ions interacting
with ligands. Similar to zinc, cobalt forms octahedral, tetrahedral and trigonal bipyramidal
geometries depending on the ligands.37

Methionine aminopeptidases are ubiquitous enzymes that cleave the N-terminal
methionine from newly translated polypeptide chains in both prokaryotes and eukaryotes. The
enzyme from Salmonella typhimurium is stimulated only by Co2+, not by Mn2+, Mg2+, or Zn2+.
However, when purified, the enzyme does not contain significant amounts of any metal ions;
enzymatically important cobalt is loosely associated and so the identity of the metal ion bound in
vivo has not been firmly established. However, the enzyme from E.coli has been shown by X-ray
crystallography to contain cobalt ions. The E.coli methionine aminopeptidase binds two Co2+
ions in its active site.30 The enzyme has several weak absorption bands between 550 and 700 nm
(d d transitions of the d7 Co2+ ions).38 Understanding the interactions of cobalt with the active
site residues, substrate and inhibitors are important for rational drug design targeting specific
19

cobalt metalloenzymes.39-41 In the enzyme, the two cobalt ions are coordinated by two Asp, one
His, and two Glu residues, all conserved in several methionine aminopeptidases analyzed except
for one of the Glu that is substituted by Gln in the Bacillus subtilis enzyme. The two cobalt ions
bond to each other; each also bond to four other atoms, with one cobalt binding the ring N of the
His, one O of the Glu204, one O of Glu235 and one O of Glu108. The other cobalt coordinates to
four O atoms, one from Glu235, two from Asp97 and a fourth from Glu108. These Co-O and
Co-N bonds occupy the equatorial bonds of the octahedral geometry except the one with the O
atom of Glu235 that occupies the axial position (5th coordination) for each cobalt. The 6th
coordination site at the active site is not occupied and likely bond to a solvent water molecule.38
1.4. Manganese Ion (II)
Manganese (Mn) is a required enzyme cofactor in many enzymes. It plays a significant
role in many biochemical processes in plants.42,43 It usually acts as an enzyme activator. It is easy
to be replaced by other divalent metal cations (often Mg2+). Therefore Mn has similar
biochemical function as Mg and is involved in activating enzyme catalyzed reactions such as
phosphorylation, decarboxylation, reduction and hydrolysis reactions. It affects processes such as
respiration, amino acid synthesis, lignin biosynthesis and the level of hormones in plants.42
Mn has a low affinity for binding ligands compared to other metal ions based on the order
of the stability trend for complexes of bivalent transition metals, namely Mn < Fe < Co < Ni <
Cu > Zn.43 Mn2+ complexes are thermodynamically less stable than the other metal ions in the
trend above because of the lack of ligand-field stabilization energy, which can be traced back to
the symmetric d5 electron configuration system of the Mn2+ ion.44 For example, in for the
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octahedral complex, the stabilization contributed by the three electrons in the t2g is canceled by
the two in the eg. Octahedral coordination makes the complex less stable and an unfavorable
geometry for Mn2+.45
An example of a manganese metalloenzyme is prolidase, a proline dipeptidase in humans
and microorganisms and is important for recycling proline required for the production of
collagen, a structural component of various tissues such as the skin. Manganese is therefore
important for everyday skin health.46 Prolidase has a dinuclear Mn2+ and specifically cleaves the
peptide bond between Xaa and Pro in Xaa-Pro dipeptides. 30 Each active-site Mn2+ ion forms six
coordination bonds thus assuming a distorted octahedral geometry. Two of the bonds are formed
by an Asp and a Glu residue each of which acting as a bidentate ligand bridging the two Mn2+
ions. Two additional bonds are formed with a His (H) and a Glu (E) residue to one Mn2+ but with
two Asp (D) residues to the other. The 5th and 6th coordination bonds on each Mn2+ are formed
with a buffer component glycolate which acts as a bidentate chelator through its carboxyl and the
hydroxyl oxygens (Figure 1.3).47
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Figure 1.3 The structure of the binuclear Mn+2 center and the bound putative glycolate molecule (in
green) in prolidase enzyme.47

In addition to its collagen production role, manganese also functions as an antioxidant in
skins cells and other cell types. It helps protect skin against oxidative damage as well as damage
from ultraviolet (UV) light.46 This is due to manganese being a redox-active metal48 and is found
at the active site of the mitochondrial superoxide dismutase SOD2 (Mn-SOD). SOD1 in cytosol
and SOD3 in extracellular matrix are the other known human isoforms of SOD which contain
Cu-Zn and Fe, respectively, at the active site. Mn-SOD are also found in various bacteria. SOD
catalyzes the conversion of superoxide radicals to hydrogen peroxide which can then be reduced
to water by antioxidant enzymes such as catalyse. Mn therefore helps protect cells against the
toxicity of the superoxide free radicals.49
Another example of a manganese metalloenzyme is arginase. Arginase is required in the
liver for catalyzing the physiologically important final step in the urea cycle, facilitating the
removal of nitrogenous waste during protein catabolism.49 The enzyme requires a dinuclear
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manganese cluster to maintain proper function. As in prolidase, the two Mn2+ ions are bridged by
the carboxyl groups of two Asp residues. Both Mn2+ also bond to additional residues including a
His and an Asp residue each with one Mn2+ forming two bonds with the corresponding Asp.
These two Mn2+ ions also coordinate with the substrate water molecule as its 5th or 6th
coordination bond. As such, the two Mn2+ ions help orient and stabilize the water, allowing it to
act as a nucleophile to attack L-arginine, hydrolyzing it into ornithine and urea.50
In light of the essential functions that manganese metalloenzymes play, manganese
deficiency in experimental animals are associated with biochemical and structural abnormalities
and diseases. Deficient animals can be characterized by impaired insulin production, alterations
in lipoprotein metabolism, an impaired oxidant defense system, and perturbations in growth
factor metabolism. If the deficiency occurs during early development, there can be pronounced
skeletal abnormalities and an irreversible ataxia. Several lines of evidence suggest that
manganese deficiency may be a problem in some human populations.51
Low dietary manganese or low levels of manganese in blood or tissue have also been
associated with several chronic diseases in humans. For example, women with osteoporosis have
decreased plasma or serum levels of manganese and also an enhanced plasma response to an oral
dose of manganese, suggesting they may have lower manganese status than women without
osteoporosis. Manganese deficiency also results in glucose intolerance similar to diabetes
mellitus in some animal species.52,53
Excess manganese can also pose a significant health risk. Manganese toxicity may result
in multiple neurologic problems and is a well-recognized health hazard for people who inhale
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manganese dust, such as welders and smelters.51,52 Unlike ingested manganese, inhaled
manganese is transported directly to the brain before it can be metabolized in the liver.53 The
symptoms of manganese toxicity generally appear slowly over a period of months to years. In its
worst form, manganese toxicity can result in a permanent neurological disorder with symptoms
similar to those of Parkinson's disease, including tremors, difficulty walking, and facial muscle
spasms.54,55 Additionally, environmental or occupational inhalation of manganese can cause an
inflammatory response in the lungs.56 Clinical symptoms of effects to the lung include cough,
acute bronchitis, and decreased lung function.57
1.5. Metalloenzymes (II)
Metalloenzymes are involved in an extensive range of biological processes, and their
over- expression often coincides with various diseases. Metalloenzymes such as histone
deacetylase (HDAC) play an integral role in the proliferation of tumor cells, angiogenesis and
many other processes. Inhibiting HDAC therefore can be a mode of cancer treatment.58 The
American Cancer Society estimates that in 2015 there were over 500,000 deaths in the United
States that resulted from the four major cancers – colon and rectum, lung and bronchus, breast,
and prostate.58 Developing new therapies to treat cancer is a major focus of the pharmaceutical
industry as well as in academia, and metal-inhibitors are one potential therapeutic approach.
Inhibition of metalloenzymes is often dependent on the ability of the inhibitor to bind the active
site metal ion. Understanding the energetics of this active site metal ion-inhibitor interaction can
aid in the design of potent and selective inhibitors.58 Current FDA approved metalloenzyme
inhibitors are associated with many adverse effects such as nausea and blood disorders because
the inhibitors also bind other metalloenzymes as well as other metal ion pools in the body.
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Therefore identifying a way to target inhibitors to specific metalloenzymes is essential in
minimizing adverse effects.5
The interaction of metalloenzymes with inhibitors is often studied using the isolated enzyme.
Such studies give information about the overall energetics of the interaction but do not allow for
the extraction of the energetic contribution of individual components of the interaction – such as
active site metal binding by the inhibitor. In addition, the complexity of making and using
significant amounts of pure enzyme makes this approach impractical for most enzymes On the
other end of the spectrum of complexity, the energetics of the inhibitor binding to the free metal
ion can be determined, but it does not equate the energetics of the inhibitor binding to the active
site metal ion. A better alternative is to use an enzyme active site metal ion structural mimetic
formed by a metal ion bound to a ligand consisting of the same or similar set of coordinating
atoms as in the enzyme active site. In this study, we are examining the potential of three metal
ions – Cu2+, Co2+, and Mn2+- with five different ligands to form suitable structural mimetics.
Specific information about each of the five different ligands is given below. The interactions of
each ligand with each of the metal ions and the interaction of the resulting metal-ligand
complexes with metalloenzyme inhibitors are detailed in the following chapters.
1.6. Supporting Ligands
The ligands used in the study are DA2Im (N-(2-(1-methylimidazolyl)methyl)
iminodiacetic acid), NTA (nitrilotriacetic acid), TREN (tris(2-aminoethyl)amine), TPA (tris(2pyridylmethyl)amine), and BPA (bis(2-picolyl)amine). In order for these ligands to be
considered as a potential enzyme active site structural mimetic, they need to meet several
requirements. It is imperative that the ligand chelates the metal ion (II) strongly and the resulting
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complex remain intact upon binding to the inhibitor. If the inhibitor binds more strongly than the
ligand for the metal ion (II), it could displace the ligand. A second requirement is that the
stoichiometric ratio of the ligand (either tri- or tetra-dentate) to M2+ in the complex be 1:1. Note
that the supporting ligand used is tri- or tetra-dentate and that Cu2+, Co2+, and Mn2+ each can
form up to 6 coordination bonds in solution.59 Therefore, a ML complex ensures that additional
coordination sites are available on the M2+ ion for inhibitor interaction. However, an ML2
complex will not be suitable since no coordination site will be available to inhibitor binding. The
final requirement is that the structural mimetic must be soluble at concentrations necessary for
ITC study (0.1-10 mM). Buffer solutions chosen for the study include a 50 mM buffer (NEM (Nethylmaleimide) or Tris (tris(hydroxymethyl)aminomethane)) containing 0.15 M NaCl at pH
6.80, 7.25 or 7.40 and a 60:40 by volume mixture of MeOH: buffer at pH 6.80, 7.25 or 7.40.
These buffers are relatively close to biological systems when compared to pure organic solvents.
The individual properties of the ligands are outlined below.
1.6.1 DA2Im
N-(2-(1-methylimidazolyl)methyl)iminodiacetic acid (DA2Im) (Figure 1.5), a tertiary
amine having two carboxylate groups (pKa1 = 2.72, pKa2 = 4.20) along with a single
methylimidazole group (pKa3 = 8.09) 59, was synthesized in Dr. Grice’s lab with his guidance.
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Figure 1.5 N-(2-(1-methylimidazolyl)methyl)iminodiacetic acid (DA2Im).
DA2Im is a tetradentate ligand that can coordinate to transition metal ions with its carboxylic
acid oxygens, tertiary amine, and imidazole nitrogen. It is designed to mimic the groups of a His
and two Asp or Glu residues commonly found to bind to transition metal ions at zinc- or cobaltcontaining enzymes.59
1.6.2 NTA
Commercially available nitrilotriacetic acid (NTA) (Figure 1.6) is a tertiary amine with
three acetate groups (pKa1 = 1.87, pKa2 = 2.53 and pKa3 = 9.40)

59

and thus can act as a

tetradentate ligand. The acetate groups mimic Glu or Asp sides chains often seen involved in
coordinating to enzyme active site metal ions.

27

O
O

O
NH

O
O

O

Figure 1.6 Nitrilotriacetic acid (NTA)
1.6.3 TREN
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Figure 1.7 Tris(2-aminoethyl)amine (TREN).
Commercially available tris(2-aminoethyl)amine (TREN) (Figure 1.7) is a tetradentate ligand
that binds M2+ with its three primary amines (pKa1 = 8.42, pKa2 = 9.42, pKa3 = 10.13) and tertiary
amine.59 Although primary amines are not commonly involved in coordinating to enzyme active
site metal ions, they nonetherless represent groups that are capable of coordinating to metal ions
when deprotonated and are potential candidates for creating enzyme active site metal ion
structural mimetics.
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1.6.4 TPA
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Figure 1.8 Tris(2-pyridylmethyl)amine (TPA).
Commercially available tris(2-pyridylmethyl)amine (TPA) (Figure 1.8) was explored as a
potential ligand to form the enzyme active site structural mimetic. TPA is a tetradentate ligand
that is a tertiary amine with three pyridylmethyl groups (pKa1 = 2.55, pKa2 = 4.35 and pKa3 =
6.17)59, making it a potentially tetradentate ligand for chelating M2+ through its three pyridine
nitrogens and the tertiary amine nitrogen. The pyridyl nitrogens have properties close to the
imidazole nitrogen of histidine residue commonly bound to enzyme active site metal ions.
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1.6.5 BPA
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Figure 1.9 Bis(2-picolyl)amine (BPA).
BPA is a tridentate ligand that can coordinate to M2+ with its two pyridyl nitrogens and the
secondary amine. BPA (Figure 1.9) resembles TPA except that it is a secondary amine bonded to
two rather than three 2-pyridylmethyl groups (pKa1 = 1.75, pKa2 = 2.41 and pKa3 = 7.27).59 This
makes BPA a tridentate ligand for chelating M2+.
1.7. Solution Conditions
NEM was used as the buffer component for the study involving Co2+ and Mn2+. NEM was
chosen for its pKa value of 7.67 60 and for its lack of affinity for transition metal ions. In the case
of Cu2+, due to its strong tendency to form Cu(OH)2 precipitate thus its low solubility in aqueous
solution, Tris buffer was used instead. Tris binds transition metal ions and therefore was able to
solubilize Cu2+ to high enough concentration necessary for the ITC study. However, the resulting
affinity constants for Cu2+ interacting with ligands were apparent (observed) constants, lower
than it would be in the absence of Tris. As detailed in later sections, this would not affect the
relative affinity of the five ligands for Cu2+ nor the determination of the stoichiometry of the
resulting Cu2+ ligand complexes.61
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Tris, with its pKa of 8.1, is commonly used as a buffering system for the pH range of 7-9.
Nevertheless, it should be noted that Tris shows copper-complexing capacity and henceforth will
not only affect the apparent affinity of copper for other ligands but may also influence the
stoichiometry in the complexes formed.61 In this work, the associations of five small molecule
ligands with Cu2+, Co2+, and Mn2+ were examined utilizing Isothermal Titration Calorimetry
(ITC) to identify ligands capable of forming binary complexes as potential structural mimetics
for enzyme active site metal ion. First, the interaction of each of the five ligands with a given
metal ion was examined in the buffer or the methanol: buffer mixture depending on their
solubility in each.
The subsequent potential mimetics, i.e., the binary complexes as ML, were further
examined in its interaction with the metal chelator and known enzyme inhibitor, 8hydroxyquinoline (8-HQ). 8-HQ was chosen as the inhibitor molecule for its moderate metal ion
affinity required for unambiguous determination of the feasibility of the binary complex as an
enzyme active site structural mimetic. The thermodynamics of the binary complexes interacting
with the enzyme active site inhibitor prototype, acetohydroxamic acid (AHA), was also
evaluated using ITC and UV-Vis spectroscopy.
1.8. Isothermal Titration Calorimetry
Isothermal titration calorimetry (ITC) is an efficient analytical method to determine the
thermodynamic parameters for a given interaction and can be applied over a broad range of
systems. ITC works by measuring the heat produced during a titration reaction. Upon titration of
one reactant (titrant) placed in the syringe and injected in a series of small volumes (8-15 μL)
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into the 1.4 mL of solution containing the other reactant (titrate), the difference in heat between
the thermocouple reference cell and the sample cell is measured upon a series of injections. Since
the titrant is injected in such small volumes, a large dilution factor is associated with the
injection. The raw data from the experiment is plotted as the heat power (μcal/sec) versus time
(minutes). The zone under each peak is calibrated and standardized to kcal/mole of titrant and
plotted against the titrant: titrate molar ratio. This plot is fit with a non-direct least squares
utilizing an appropriate binding model, for example, the one-set-of-sites or two-sets-of-sites
models incorporated into the Origin software package62,63 Heat is either released (negative peaks)
reflecting an exothermic reaction or absorbed (positive peaks) indicating an endothermic
reaction. The heat of reaction is measured through the amount of power required to maintain a
difference in temperature between the reference and sample cells equal to zero. With subsequent
additions of titrant, the heat signal diminishes, indicating that binding is near completion. The
concentrations of titrant and titrate are chosen so that only a portion of titrant binds upon each
titration. This makes the final binding curve of heat generated per injection versus titrant: titrate
molar ratio dependent on the molar enthalpy change for the binding response (ΔH°), the affinity
consistent (Ka), and the stoichiometric proportion between the two interacting species in the
subsequent complex (n). These parameters would then be able to be utilized to compute other
valuable parameters, for example, the standard Gibbs free energy change (ΔG°), the equilibrium
dissociation constant (Kd) and the entropy change for the reaction (ΔS°). Further information
about ITC analysis is provided in the Experimental Methods in Chapter 6. 59, 63
A c value is used to determine the acceptable range of concentrations to be used in a titration
experiment. It is defined as the products of stoichiometry (n, ratio of the titrant to titrate in the
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complex formed), equilibrium binding constant (Ka) and the concentration of titrate in the form
of c = n Ka C. The optimal c-values is 1-1000 but the ideal range is 5-500. This ensures that the
resulting binding isotherm best defines thus the most accurate extraction of a set of binding
parameters including n, Ka and H (molar enthalpy change of the binding reaction). An ideal
titration curve is shown in Figure1.10 has a unique shape. Notably, to shift binding to
completion, the titrant concentration is chosen to be at least ten times the titrate concentration for
a 1:1 binding or 20 times the titrate concentration for a 2:1 binding.62

Figure 1.10. An S-shaped curve is the ideal shape of a binding isotherm for accurate extraction
of binding parameters. The line is a curve that best fit the data and is obtained from fitting to a
one set of sites binding model.62
Chapter 2: ITC Studies of the Interactions of Ligands with Metal Ions(II)
2.1 ITC Studies of the Interactions of Ligands with Cu2+
2.1.1 N-(2-(1-methylimidazolyl)methyl)Iminodiacetic Acid (DA2Im) Interaction with Cu2+
No structure of DA2Im bound with a metal ion is reported in the literature. The
interaction of DA2Im with Cu2+ was studied in buffer but not in MeOH:buffer mixture due to the
low solubility of DA2Im in the latter. Injection of DA2Im (8.8 mM) into CuCl2 (0.33 mM) in 50
33

mM Tris buffer (0.15 M NaCl, pH 7.4) resulted in a binding isotherm that, after omitting the first
six data points, fit well to a one-set-of-sites binding model (Figure 2.1). The overall binding
stoichiometry was close to 2 (n = 1.84 ± 0.05) indicating two DA2Im binding each Cu2+ ion. The
resulting Ka was (3.15 ± 0.07) ×103 M-1. Given the fact that the first 5 peaks exhibited similar
heat suggests that the first DA2Im bound Cu2+ with very strong affinity such that all DA2Im
injected bound Cu2+. This prevented the determination of the binding constant for the first
DA2Im. However, the much stronger affinity of the first DA2Im also made it possible to form a
1:1 (DA2Im:Cu2+) binary complex without the presence of a significant percentage of a 2:1
(DA2Im:Cu2+) complex by controlling the molar ratio of DA2Im:Cu2+ at 1:1. To determine the
Ka for the first DA2Im binding, we lowered the concentration of DA2Im to 1 mM and titrated it
into 0.1 mM CuCl2. The resulting binding isotherms fit well to a one-set-of-sites model (Figure
2.2) and yielded a very high apparent affinity constant of (4.35 ± 0.06) x108 M-1 and an n value
of 0.97 ± 0.01 DA2Im per Cu2+ (Table 2.1), confirming our hypothesis that DA2Im and Cu(II)
formed a strong Cu(DA2Im) binary complex. At this low concentration, the second binding
which has an affinity constant of (3.15 ± 0.07) ×103 M-1 was not observed. In summary, the Cu2+
ion was capable of binding one DA2Im very strongly (Ka ~108 M-1) and a second DA2Im weakly
(Ka ~103 M-1). Notably, ITC date was only able to determent molar ratio between the ligand and
the metal and it does not show if the Cl- bind or not.
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Figure 2.1. Raw data (top panel) and binding isotherm (bottom panel) for titrations of 8.8 mM
DA2Im into o.33 mM CuCl2 in Tris buffer, pH 7.4, 25C.

35

Figure 2.2. Raw data (top panel) and binding isotherm (bottom panel) for titrations of 1 mM
DA2Im into 0.1 mM CuCl2 in Tris buffer at pH 7.4, 25 C.
Table 2.1 Thermodynamic parameters from ITC study of DA2Im interaction with Cu2+ in 50
mM Tris buffer (0.150 M NaCl, pH 7.40).*
n
Ka
Kd
ΔG°
ΔH°
TΔS°
(DA2Im/Cu2+)
(M-1)
(μM)
(kcal/mol)
(kcal/mol)
(kcal/mol)
High Conc.
(3.15 ± 0.07) x103
(3.18 ± 0.07) x102
-4.8 ± 0.0
-4.8 ± 0.1
1.01 ± 0.12
1.84† ± 0.05
8
Low Conc.
0.97 ± 0.01
(4.35 ± 0.06) x10
2.29 ± 0.03
-9.74 ± 0.3
3.42 ± 0.17
13.15 ± 3.30
* Titrations of 8.8 mM DA2Im into 0.33 mM Cu2+ and titrations of 1 mM DA2Im into 0.1 mM Cu2+.
† The n value obtained at the high concentrations indicate the total number of DA2Im bound but the K a obtained here was
for the second DA2Im as it resulted from deleting the first six data points corresponding to the first DA2Im binding.

2.1.2 Nitrilotriacetic Acid (NTA) Interaction with Cu2+
The interaction of NTA with Cu2+ was investigated in buffer but not in MeOH:buffer
because NTA was insoluble in the latter. Experiments were performed by titrating NTA into
CuCl2. The resulting binding isotherms fit well to a one-set-of-sites model (Figure 2.3) and
yielded a high apparent affinity constant of (4.6 ± 0.3) ×106 M-1 and an n value of 1.01 ± 0.03
NTA per Cu2+ (Table 2.2), indicating the formation of a Cu(NTA) binary complex. This made
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NTA a potentially suitable ligand for creating an enzyme active site copper structural mimetic. It
should be noted that NTA and Cu2+ binding isotherm was endothermic, unlike for DA2Im for
which it was exothermic, likely the result of the fact the 2-(1-methylimidazolyl)methyl group in
DA2Im is replaced with an acetate group in NTA. The endothermic heat suggests loss of overall
bonding in the process of NTA and Cu2+ desolvation and subsequent formation of complex with
each other. The NTA and Cu2+ complex formation evidently was driven by entropy as a result of
the entropic gain from releasing water molecules from the solvation shell of the carboxyl anions
and the Cu2+ cation.
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Figure 2.3. Raw data (top panel) and binding isotherm (bottom panel) for titrations of 1.5 mM
NTA into 0.15 mM CuCl2 in Tris buffer, pH 7.4, 25 C.

Table 2.2. Thermodynamic parameters from ITC study of NTA interaction with Cu2+ in 50 mM
Tris buffer (0.150 M NaCl, pH 7.40).*
n
Ka
Kd
(NTA/Cu2+)
(M-1)
(μM)
1.01 ± 0.03
0.22 ± 0.01
(4.6 ± 0.3) ×106
*Titration of 1.5 mM NTA into 0.15 mM Cu2+

ΔG°
(kcal/mol)
-9.09 ± 0.04

ΔH°
(kcal/mol)
1.71 ± 0.02

TΔS°
(kcal/mol)
10.8 ± 0.1

2.1.3 Tris(2-aminoethyl)amine (TREN) Interaction with Cu2+
The interaction of commercially available tris(2-aminoethyl)amine (TREN) with Cu2+
has been studied by Kay et al.63 They reported the crystal structure of Cu(TREN) with one 2aminoethyl amine arm deprotonated. Another study showed a crystal structure of two Cu2+
bound to one TREN and two Cl- with two BPh4 as the counter ions in the formula of
[Cu2(tren)2Cl2](BPh4)2.64 ITC experiments with TREN consisted of TREN being titrated into a
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solution of copper in either 50 mM Tris buffer (0.15 M NaCl, pH 7.40) or 60:40 (by volume)
MeOH: buffer (50 mM Tris, 0.15 M NaCl) mixture at pH 7.40. Titration of 0.15 or 0.5 mM
TREN into 0.015 or 0.05 Cu2+ in buffer or in MeOH: buffer, respectively demonstrated that the
interaction was exothermic and binding isotherms fitted well to a one-set-of-sites binding model
in both solution conditions (Figures 2.4 and 2.5). Fitting yielded an n value of 1.07 ± 0.05 TREN
per Cu2+ in buffer and 1.04 ± 0.0 TREN per Cu2+ in methanol:buffer mixture (Table 2.3),
indicating that a binary complex of Cu(TREN) has formed in either medium. This result agreed
with the finding by A. Bencini et al. that copper (II) yields a mononuclear trigonal-bipyramidal
complexes with TREN.65 The apparent binding affinity (Ka) of Cu2+ for TREN was (2.3 ± 3.1)
×108 M-1 in buffer or (4.8 ± 1.8) ×107 M-1 in MeOH:buffer. The weaker affinity in buffer can be
explained by the competition of protons for binding the tertiary and the three primary amine
groups. In MeOH:buffer, the presence of methanol disfavors the protonation of the amines thus
less extensive proton competition. This is consistent with stronger affinity in methanol:buffer
mixture. Overall, in both media, TREN formed a strong binary complex with Cu2+. The strong
affinity makes TREN in the binary complex less prone to be displaced by the inhibitor when the
complex is used for the inhibitor binding study.
Table 2.1. Thermodynamic parameters from ITC study of TREN interaction with Cu2+ in either
50 mM Tris buffer (0.150 M NaCl, pH 7.40) or 60:40 (by volume) mixture of MeOH: 50 mM
Tris buffer (0.150 M NaCl, pH 7.40).*
n
Ka
Kd
ΔG°
ΔH°
Solvent
(TREN/Cu2+)
(M-1)
(μM)
(kcal/mol)
(kcal/mol)
Buffer
1.1 ± 0.1
(4.8 ± 1.8) x107
0.02 ± 0.01
-10.4 ± 0.2
-2.7 ± 0.1
MeOH:Buffer
1.0 ± 0.0
(2.3 ± 3.1) x108
0.01 ± 0.01
-11.0 ± 0.9
-3.4 ± 0.3
*Titrations of (0.15 or 0.5) mM TREN into (0.015 or 0.05) Cu 2+ in buffer and MeOH:Tris buffer, respectively.
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TΔS°
(kcal/mol)
7.7 ± 0.2
7.6 ± 0.9

Figure 2.4. Raw data (top panel) and binding isotherm (bottom panel) for titration of 0.15 mM
TREN into 0.015 mM CuCl2 in Tris buffer, pH 7.4, 25 C.
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Figure 2.5. Raw data (top panel) and binding isotherm (bottom panel) for titrations of 0.5 mM
TREN into 0.05 mM CuCl2 in 60:40 (by volume) mixture of MeOH: Tris buffer, pH 7.4, 25 C.

2.1.4 Tris(2-pyridylmethyl)amine (TPA) interaction with Cu2+
TPA was found to be insoluble in Tris buffer, pH 7.4 at the concentration necessary for
ITC experiments; therefore, ITC experiments were carried out in 60:40 (by volume) MeOH:Tris
buffer, pH 7.4. When 0.75 mM of TPA was titrated into 0.075 mM of CuCl2 the resulting data
was fit to a one-set-of-sites binding model (Figure 2.6), which yielded an apparent affinity
constant (Ka) of (3 ± 2) × 107 M-1 and a stoichiometric ratio of 1.21 ± 0.03 TPA per Cu2+,
corresponding approximately to a complex of 1:1 (TPA: Cu2+) molar ratio (Table 2.4). This
stoichiometric ratio met the requirement for a 1:1 binary complex for it to serve as an enzyme
active site copper structural mimetic. X-ray crystallographic studies suggest that TPA, a tripodal
tetradentate ligands, forms a square pyramidal Cu2+ complex in the presence of Cl- ion which
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forms the 5th coordination bond in the complex.66 Replacing a methylene with an ethylene group
linking the central aliphatic nitrogen to the pyridyl group in TPA instead leads to the formation
of a trigonal bipyramidal complex also having Cl- forming the 5th coordination bond.66 This
suggests that ligand constraints is responsible for the markedly different structural behavior and
also redox and electronic properties of the copper(II) complex. Regardless of the geometry, this
work indicates that Cu(II) forms 1:1 complex with TPA. This is confirmed by Hirotaka Nagao et
al. who also reported a Cu(II) TPA complex with the formula of [Cu(TPA)(H2O)]2+ at pH 7.0.
Therefore, out ITC data is consistent with literature reports in the formation of a 1:1 (Cu2+ :
TPA) complex.67

Figure 2.6. Raw data (top panel) and binding isotherm (bottom panel) for titrations of 0.75 mM
TPA into 0.075 mM CuCl2 in 60:40 (by volume) mixture of MeOH:Tris buffer, pH 7.4, 25 C.
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Table 2.4. Thermodynamic parameters from ITC study of TPA interaction with Cu2+ in 60:40
(by volume) mixture of MeOH:Tris buffer, pH 7.4*
Ka
Kd
(M-1)
(μM)
1.21 ± 0.03
(3.0 ± 2.0) x107
0.05 ± 0.04
*Titrations of 0.75 mM TPA into 0.075 Cu 2+
n (TPA/Cu2+)

ΔG°
(kcal/mo)
-10.1 ± 0.5

ΔH°
(kcal/mol)
-5.4± 0.8

ΔS°
(cal/(mol·))
16.0 ± 4.0

TΔS°
(kcal/mo)
5.0 ± 1.0

2.1.5 Bis(2-picolyl)amine (BPA) Interaction with Cu2+
Bis(2-picolyl)amine (BPA) (Figure 1.9) was studied as a potential ligand to develop an
enzyme active site structural mimetic. BPA is a well-known tridentate ligand capable of donating
three electron pairs to a cationic metal center. Its geometry and its conformational flexibility
gives this ligand a strong affinity for biologically interesting Cu2+ and Zn2+ ions. The tridentate
amine – metal chelation also leaves basic coordination positions free of counterions.68 Cu(II) is
known to form complexes in solution in coordination numbers of 4, 5, or 6.4,21 Therefore, with a
tetradentate ligand, Cu2+ is more likely to form a 1:1 (Cu2+:ligand) complex and the resulting
CuL complex will still have two coordination sites remaining to interact with other coordinating
atoms such as from a bidentate ligand, amenable to serving as an enzyme active site copper
structural mimetic. For a tridentate ligand, it is likely that Cu2+ will form a 2:1 (Ligand:Cu2+)
complex, leaving no or insufficient coordination sites for inhibitor binding since the octahedral
geometry preferred by Cu2+ provide only six coordination sites, unless the second ligand binds
with orders of magnitude weaker affinity than the first ligand in which case a strong 1:1 complex
can be formed.
The interaction of BPA with Cu2+ was studied in both the buffer and the MeOH:buffer
mixture by titrating BPA into CuCl2. Two buffers, Tris and NEM, were used in the study. ITC
experiments were done by titrating BPA into CuCl2 at various concentrations such as 10 mM
BPA into 0.5 mM Cu2+ or 0.3 mM BPA into 0.03 mM Cu2+. (Figure 2.7). Binding isotherms
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from experiments performed in NEM solvent systems (buffer or MeOH:buffer mixture) were fit
to a one-set-of-sites binding model, while those performed in Tris solvent systems (buffer or
MeOH:buffer mixture) were fit to a sequential binding model with n equal to 2 (Figure 2.7). In
Tris solvents, the stoichiometry of 2 is consistent with the crystal structure in the presence of
BF4- as counter ion as reported by Palaniandavar et al.

21

Another crystallographic study also

showed that Cu(II) bound two BPA forming Cu(BPA)2(ClO4)22H2O.69 In Tris buffer or the
MeOH:Tris buffer mixture, the ITC binding curves suggest that the two BPA molecules bound
Cu2+ with different affinity (Table 2.5). In Tris buffer, the second BPA bound Cu2+ with 3-orders
of magnitude lower affinity than the first BPA. However, in MeOH:Tris, the second BPA bound
2-orders of magnitude more weakly than the first. Weaker BPA binding has also been reported
for Zn2+ except that Zn2+ binds the second BPA with 4-orders of magnitude lower affinity than it
does the first BPA.59 This is consistent with the known difference between Cu2+ and Zn2+ in that
Cu2+ is capable of hexacoordination.59
The results in the NEM solvent systems (NEM buffer or MeOH:NEM buffer mixture)
differed from those in the Tris solvent systems. The binding curves suggest that only one BPA
molecule bound Cu2+ with no evidence for the presence of a second BPA. The affinity of the
BPA was one-order of magnitude higher in NEM buffer than in the MeOH:NEM mixture (Table
2.5). This difference in the types of complexes formed in Tris versus NEM buffer can be
attributed to the fact that much higher concentrations of BPA and Cu2+ were used in Tris buffer
given the presence of Tris competition with BPA to bind Cu2+. In Tris the higher concentrations
helped detect the weak binding of a second BPA while in NEM the lower concentrations allowed
only the detection of the stronger binding of the first BPA. The difference in the metal ion ability
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of NEM versus Tris explains the weaker BPA affinity in the MeOH:buffer mixture using Tris
(Ka = (1.8±0.2) x105 M-1) than using NEM as buffer (Ka = (2.73±0.68) x106 M-1).
Given that the second BPA binds Cu2+ with orders of magnitude weaker affinity than the
first BPA, a strong Cu(BPA) binary complex can be formed by mixing BPA with CuCl2 at 1:1
molar ratio and used to test its potential as an enzyme active site copper structural mimetic,
specifically in its ability to interact with a metalloenzyme inhibitor.
It should also be noted that in a given buffer systems (Tris or NEM), BPA bound Cu2+
with lower affinity in the presence of MeOH, given that Ka is (5.0±2.0) x106 M-1 in NEM buffer
but (2.73±0.68) x106 M-1 in MeOH:NEM mixture or (3.3±1.5) x107 M-1 in Tris but (1.8±1.0)
x105 M-1 in MeOH:buffer mixture for both the first and the second BPA (Table 2.5). This was an
unexpected result since methanol lowers the pKb of nitrogeneous bases70, therefore less
deprotonation would be coupled to copper coordination in MeOH:buffer than in buffer. Another
factor must be responsible for the lower affinity in the presence of methanol. One possibility is
the difference in Cu2+ ion solvation. In the presence of methanol, Cu2+ is less solvated by water
and thus the gain of entropy upon release of the solvated water when Cu2+ binds BPA is less in
the presence of methanol.
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a)

b)

C)

d)

Figure 2.7. Raw data (top panel) and binding isotherm (bottom panel) for titration of a) 10 mM
BPA into 0.5 mM CuCl2 in Tris buffer, pH 7.4, 25 C. b) 0.08 mM BPA into 0.004 mM CuCl2 in
NEM buffer, pH 6.80, 25 C. c) 10 mM BPA into 0.5 mM CuCl2 in 60:40 (by volume) mixture
of MeOH:Tris buffer, pH 7.40, 25 C. d) 0.3 mM BPA into 0.03 mM CuCl2 in 60:40 (by
volume) mixture of MeOH:NEM buffer, pH 6.80, 25 C.
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Table 2.5. Thermodynamic parameters from ITC study of BPA titration into CuCl2 in buffer and

Solvent
Tris Buffer
NEM Buffer
MeOH:Tris
Buffer
MeOH:NM
Buffer

n
(BPA/Cu2+)

Ka
(M-1)

Sequential
Binding Sites
n=2
1.03 ± 0.14
Sequential
Binding Sites
n=2
0.85 ± 0.06

(3.3 ± 1.5) x107
(1.16 ± 0.08)

x104

Kd
(μM)

ΔG°
(kcal/mol)

ΔH°
(kcal/mol)

TΔS°
(kcal/mol)

0.03 ± 0.0

-10.3 ± 0.0

(-2.38±0.05) x103

-7.9 ± 0.0
-2.1 ± 0.0

86.2± 0.0

-5.5 ± 0.0

(5.0 ± 2.0)
(1.8 ± 0.2) x105
(5.0±4.2) x103

0.20±0.06
6.4 ± 3.0
(3.0± 2.1) x102

-9.13 ± 0.18
-7.1 ± 0.3
-5.0 ± 0.5

-6.70±0.05
(5.3±1.0) x102
(-9.0± 4.3) x103

2.4 ± 0.2
-7.6± 0.4
-4.0 ± 0.4

(2.73±0.68) x106

0.37±0.09

-8.8 ± 0.2

-18.3± 1.3

-9.5 ± 1.5

x106

(-7.7± 0.1)

x103

MeOH (60:40 by volume) mixture of MeOH:Tris buffer, pH 7.4, 25 C.*
* From titration of 10 mM BPA into 0.5 mM Cu2+ in Tris and MeOH:Tris buffer, 0.08 mM BPA into 0.004 mM Cu2+ in NEM
buffer, and 0.3 mM BPA into 0.03 mM Cu2+ in MeOH:NEM buffer.

2.2 ITC Studies of the Ligands Interactions with Co2+
2.2.1 Tris(2-aminoethyl)amine (TREN) Interaction with Co2+
The interaction of Co2+ with TREN to form Co2+-TREN complex has been
reported in two solutions, water and in dimethysulfoxide (DMSO), based on absorbance
spectroscopy.71, 72 In both solutions, Co2+ forms a 1:1 strong binary complex with TREN.
In DMSO solution, a weak association of a second TREN has also been implicated.72 In
this work, to better mimic physiological conditions, the interaction of TREN with Co 2+
was studied in buffer and a MeOH:buffer mixture at pH 6.80 and 7.25. In all four-solution
conditions, the binding isotherms from titrations of TREN into CoCl2 fitted well to a oneset-of-sites binding model (Figures 2.8, 2.9, 2.10, and 2.11). In all conditions except in
buffer at pH 6.80, the fit yielded a stoichiometric ratio of a 1:1 binary complex Co2+TREN (Table 2.1). However, an n value of 0.54 ± 0.05 TREN per Co2+ was obtained in
buffer at pH 6.80 (Table 2.6), indicating the formation of a 1:2 (TREN:Co2+) ternary
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complex. Dicobalt (II) complexes have indeed been reported in aqueous solutions and a
µ-peroxo bridge linking the two cobalt ions is known.73 An additional bridge through a µhydroxo has also been reported when coordination site is available.73 A direct Co2+–Co2+
bond has also been reported for some dicobalt complexes in pure organic solvent or under
anaerobic condition but none has been reported in aqueous solution. Formation of a µperoxo bridge in Co2+ complexes is dependent on many factors such as ligand identity,
pH, and solvent polarity.72,75 The formation of cobalt a peroxo-bridge favors higher pH
and more polar solvent. Therefore the ternary complex (Co2+)2-TREN in buffer at pH 6.80
likely formed as a result of a µ-peroxo bridge. A partial if not complete charge transfer
from Co2+ to the dioxygen makes the binding of a dioxygen more likely to form73, which
could be due in part to the tertiary amine groups that have been reported to stabilize the
lower (II) oxidation state of cobalt in both aqueous and non-aqueous solutions.73-75 Given
the tendency of Co2+-TREN complex to form µ-peroxo bridge, there was a possibility that
the ITC result of a 1:1 (TREN: Co2+) complex formed in buffer at pH 7.25 and in
MeOH:buffer mixture at both pH values corresponded to a (Co2+)2(TREN)2 rather than a
Co2+-TREN complex. A (Co2+)2(TREN)2 complex has indeed been reported and has been
shown to act as a reversible O2 carrier without permanently oxidizing Co2+.72,76 It has also
been shown that the µ-peroxo bridge is favored only at higher pH.76 Since no coupled
slow process was observed in the ITC binding isotherm, if µ-peroxo and µ-hydroxo
bridging did occur, they likely had fast kinetics that rendered them integral to the process
of Co2+ binding to TREN. On the other hand, the presence of methanol in the
MeOH:buffer mixture lowers the solvent polarity and is therefore expected to disfavor the
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µ-peroxo bridge formation, making a (TREN)Co2+(µ-O2)Co2+(TREN) complex in the
MeOH:buffer mixture less likely. Additionally, a (Co2+)2-TREN complex with two cobalt
(II) coordinating to the same ligand was not observed at pH 7.25 nor in methanol:buffer at
either pH indicate that the (Co2+)2TREN complex was favored by increased proton
competition as was true at the lower pH and in the absence of methanol.

Figure 2.8. Raw data (top panel) and binding isotherm (bottom panel) for titrations of 10 mM
TREN into 1 mM CoCl2 in NEM buffer, pH 6.80, 25 C.
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Figure 2.9 Raw data (top panel) and binding isotherm (bottom panel) for titrations of 10 mM
TREN into 1 mM CoCl2 in NEM buffer, pH 7.25, 25 C.
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Figure 2.10 Raw data (top panel) and binding isotherm (bottom panel) for titrations of 0.4 mM
TREN into 0.04 mM CoCl2 in 60:40 (by volume) mixture of MeOH:NEM buffer, pH 6.80, 25
C.

51

Figure 2.11. Raw data (top panel) and binding isotherm (bottom panel) for titrations of 0.4 mM
TREN into 0.04 mM CoCl2 in 60:40 (by volume) mixture of MeOH:NEM buffer, pH 7.25, 25
C.
Regardless of the types of complex formed between Co 2+ and TREN, increasing
pH from 6.80 to 7.25 increased Co2+ affinity for TREN up to an order of magnitude (by 4and 14-fold) in buffer and MeOH:buffer mixture, respectively. The different pH
dependence of affinity in buffer versus in MeOH:buffer likely reflects the shift in binding
mode (2:1 versus 1:1 complex) in buffer. At a given pH, the interaction was two-orders of
magnitude stronger in MeOH:buffer mixture (Ka = (2 ± 1) × 106 M-1 at pH 6.8 and (3 ± 2)
× 107 M-1 at pH 7.25) than in buffer (Ka = (2.9 ± 0.4) × 104 M-1 at pH 6.80 and (1.45 ±
0.04) × 105 M-1 at pH 7.25) (Table 2.6). These trends can be explained by the reduced
proton competition for the amine groups at the higher pH and/or in the presence of
methanol. The need of the primary and tertiary ammonium ions to deprotonate in buffer
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to coordinate to Co2+ also explains the overall endothermic binding heat in buffer at pH
7.25. Binding of TREN to Co2+ in buffer at pH 7.25 was therefore entropically driven as a
result of the favourable entropic contribution from desolvation of the metal ion and the
ammonium ions. In buffer at pH 6.80, due to each TREN bonding two Co2+ ions in
forming the ternary complex which more than offset the endothermic TREN
deprotonation heat, the binding heat was exothermic and the reaction was enthalpically
driven. These results indirectly support the claim that a different complex formed at the
two pH in buffer. In the MeOH:buffer mixture, the formation of the 1:1 complex was also
enthalpically driven coupled with a small favourable (pH 6.80) or unfavourable (pH 7.25)
entropic contribution. This was consistent with the reduced need to deprotonate in the
presence of methanol. The need to deprotonate also explained the orders of magnitude
smaller conditional binding constant determined with ITC as compared with the
formation constants reported in the literature (1.20×10 13 M-1 in water and 1.45×1012 M-1
in DMSO) obtained via potentiometric method as the previously reported formation
constants do not take into account the ligand protonation equilibria.71,72,76
Table 2.6 Thermodynamic parameters from ITC study of TREN interaction with Co2+ in buffer
and MeOH 60:40 (by volume) mixture of MeOH:NEM buffer, pH (6.80, 7.25) 25 C.*
Solvent

p

N
Ka
Kd
ΔG°
ΔH°
TΔS°
2+)
(TREN/Co
H
(M-1)
(μM)
(kcal/mol)
(kcal/mol)
(kcal/mol)
6.8
0.54 ± 0.05
(2.9 ± 0.4) × 104
35 ± 5
-6.09 ± 0.08
-10.6 ± 0.9
-4.5 ± 0.9
NEM Buffer
7.2
1.09 ± 0.01
(1.45 ± 0.04) × 105
6.9 ± 0.2
-7.04 ± 0.02
6.03 ± 0.04 13.07 ± 0.04
MeOH:NEM 6.8
0.95 ± 0.04
(2 ± 1) × 106
0.4 ± 0.2
-8.7 ± 0.3
-6.3 ± 1.0
2±1
Buffer
7.2
1.02 ± 0.03
(3 ± 2) × 107
0.04 ± 0.03
-10.0 ± 0.4
-13 ± 2
-3 ± 2
* Titrations of 10 mM TREN into 1 mM Co2+ in NEM, titrations of 0.4 mM TREN into 0.04 mM Co 2+ in MeOH:NEM buffer.
Both at pH(6.8 and 7.25)

In summary, ITC results indicated that Co2+ formed a 1:1 complex in buffer at pH 7.25 and
MeOH:buffer mixture at pH 6.80 and 7.25, and a (Co2+)2-TREN ternary complex in buffer at pH
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6.80. Unlike Co2+, Zn2+ and Cu2+ form a Zn2+-TREN and Cu2+-TREN binary complex in both the
buffer and the methanol:buffer mixture, Zn2+ at NEM solvent at pH 6.80 (No pH 7.25 data
available)59 and Cu2+ at Tris solvent at pH 7.40. Despite this difference, Co2+ bound TREN with
similar affinity as Zn2+ 59 and Cu2 + do (Table 2.3).

2.2.2 Tris(2-pyridylmethyl)amine (TPA) Interaction with Co2+
Based on absorbance spectroscopic studies a 1:1 binary complex Co2+-TPA has
been reported in both water and DMSO.71,72 A Crystal structures of 1:1 (Co2+ : TPA)
binary complexes containing of various ancillary ions (including Cl-) prepared in pure
methanol have been reported.77 In this research, we chose to examine the interaction of
Co2+ with TPA in the methanol:buffer (60:40 by volume) mixtures at both pH 6.80 and
7.25. The solvent mixture helped solubilize TPA while still maintaining a physiologically
relevant solution condition. The resulting binding isotherms when TPA was titrated into
CoCl2 were fit to a one-set-of-sites binding model (Figures 2.12 and 2.13). The binary
complexes were formed at either pH, as suggested by the stoichiometric ratio of 1 TPA
per Co2+ (Table 2.7). The Co2+-TPA has been reported to be oxidized to [(TPA)Co(µOH)(µ-O2)Co(TPA)]3+ in solution but only upon lengthy (2-day) exposure to molecular
oxygen.78 Therefore, in comparison to TREN, TPA was less prone to bind dioxygen. In
fact, tertiary aminic groups and pyridic groups have been reported to stabilize the lower
(II) oxidation state of cobalt in both aqueous and non-aqueous solutions as they tend to
not bind oxygen.72,75,79-81
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Figure 2.12. Raw data (top panel) and binding isotherm (bottom panel) for titrations of 0.1 mM
TPA into 0.01 mM CoCl2 in 60:40 (by volume) mixture of MeOH:NEM buffer, pH 6.80, 25 C.
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Figure 2.13. Raw data (top panel) and binding isotherm (bottom panel) for titrations of 0.1 mM
TPA into 0.01 mM CoCl2 in 60:40 (by volume) mixture of MeOH:NEM buffer, pH 7.25, 25 C.
Curve fitting of the ITC binding isotherm yielded an affinity constant of (2 ± 1) ×
108 M-1 and (3 ± 2) × 108 M-1 at pH 6.80 and 7.25, respectively (Figure 2.12 and 2.13)
(Table 2.7). The lack of an effect of pH on the affinity constant was consistent with the
acidic pKa values of the three pyridylmethyl nitrogens. At either pH, the three
pyridylmethyl nitrogens were predominantly deprotonated prior to Co 2+ binding.
However, the current Kobs of 2-3 × 108 M-1 was still 3-orders of magnitude smaller than
the reported formation constant (logβ = 11.38 or β = 2.4×1011 M-1) 71, indicating the effect
of proton competition on metal ion binding even when the ligand was predominantly
deprotonated. Conversely, the Kobs of 2-3 × 108 M-1 was more than 2-orders of magnitude
higher than the formation constant reported in DMSO (logβ = 5.77 or β = 5.89×105 M1 72

) , highlighting the effect of solvent polarity on metal ligand affinity.
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Although Co2+ bound TREN with equal affinity as Zn2+, it bound TPA 3-times more
strongly at pH 6.8 (Ka, Co(TPA) = (2 ± 1) × 108 M-1) than Zn2+ (Ka, Zn(TPA) = (5 ± 2) × 107 M1

; no pH 7.25 data was available for Zn2+). Because Co2+ has a slightly larger ionic radius

(0.74 Å) than Zn2+ (0.72 Å) and is therefore more polarizable than Zn2+, the fact that Co2+
exhibited a stronger affinity for TPA suggests that the covalent rather than the ionic
nature of the coordination bonds predominated the interaction between Co 2+ and TPA.
This effect was evidently significant for TPA, a more polarizable ligand given its three 2pyridylmethyl groups. As described in the next section, a lesser difference was also
observed for BPA, an analog of TPA that contains two 2-pyridylmethyl groups.
Table 2.7. Thermodynamic parameters from ITC study of TPA interaction with Co2+ in 60:40
(by volume) mixture of MeOH:NEM buffer pH (6.80 and 7.25).*
pH
6.80
7.25

n
(TPA/Co2+)
1.02 ± 0.06
1.04 ± 0.07

Ka
(M-1)
(2 ± 1) × 108
(3 ± 2) × 108

Kd
(μM)
0.006 ± 0.005
0.003 ± 0.002

ΔG°
(kcal/mol)
-11.2 ± 0.5
-11.6 ± 0.4

ΔH°
(kcal/mol)
-11.8 ± 0.4
-11.5 ± 0.5

TΔS°
(kcal/mol)
-0.6 ± 0.6
0.1 ± 0.6

* Titrations of 0.1 mM TPA into 0.01 mM Co2+ in MeOH:NEM buffer at pH (6.8 and 7.25)
In summary, Co2+ formed a M2+(TPA) binary complex just as Zn2+ does in the
MeOH:buffer mixture at pH 6.80 but did so with a stronger affinity due to its larger ionic
radius and its different d orbital electron configuration. The binding constant observed in
this work is a conditional constant dependent on the protonation equilibrium and
characteristic of the pH and the medium polarity, which provided a more relevant
measure than the formation constant of the actual affinity of the Co2+ ion for the ligand.
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2.2.3 Bis(2-picolyl)amine (BPA) Interaction with Co2+
BPA was soluble in both buffer and the methanol:buffer mixture and therefore its
interaction with Co2+ was studied in both solutions at pH 6.80 and 7.25.

Binding

isotherms from titrations of BPA into CoCl2 in all four solution conditions clearly
revealed two types of binding events (Figure 2.14), suggesting weaker affinity for binding
the second versus the first BPA. The isotherms were thus fitted to a sequential-bindingsites model with the number of BPA bound per Co 2+ set as two (Figure 2.14), In all four
solution conditions, the second BPA exhibited a two-orders of magnitude lower affinity
(Ka2, buf = (2.0 ± 0.3) × 105 M-1 at pH 6.8 and (2.69 ± 0.06) × 105 M-1 at pH 7.25; Ka2,
MeOH:buf

= (2.0 ± 0.4) × 105 M-1 at pH 6.8 and (2.5 ± 0.1) × 105 M-1 at pH 7.25) than the

first BPA (Ka1, buf = (5.6 ± 0.8) × 107 M-1 at pH 6.8 and (4.6 ± 0.6) × 107 M-1 at pH 7.25;
Ka1, MeOH:buf = (3.6 ± 0.9) × 107 M-1 at pH 6.8 and (7.0 ± 0.3) × 107 M-1 at pH 7.25) (Table
2.8). Within error, affinity constants were independent of pH except for the first BPA in
MeOH:buffer where affinity (Ka1) doubled from pH 6.80 to 7.25. The lack of a significant
pH dependence of the affinity for both BPA under most solution conditions were
consistent with the very acidic pKa values of the two pyridylmethyl amines (pKa1 = 1.75,
pKa2 = 2.41) and the relatively small pH difference but inconsistent with the pKa value of
the secondary amine (7.27) which is close to the pH tested. The lack of a significant effect
of pH on BPA affinity likely suggests that the binding affinity was derived
disproportionately from coordination of the two 2-pyridylmethyl amines. The affinity was
independent of the presence of methanol at pH 6.80 but increased slightly ((4.6 ± 0.6) ×
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107 vs. (7.0 ± 0.3) × 107 M-1) in the presence of methanol at pH 7.25. The lack of a
significant effect of methanol on affinity for BPA between pH 6.80 and 7.25 was more of
a property of the ligand as a similar lack of effect is reported for Zn 2+-BPA interaction as
well59 while TREN binding exhibited strong methanol dependence for both metal ions.
A similar sequential binding of BPA with decreasing affinity has also been observed for
Zn2+ in the same buffer and methanol:buffer mixture at pH 6.80 (no pH 7.25 data
available).59 For the first BPA binding, Co2+ exhibited slightly higher affinity (by 1.3- and
0.5-fold in buffer and MeOH:buffer mixture, respectively) than Zn 2+ (Ka1, buf, Co(II) = (5.6 ±
0.8) × 107 M-1 and Ka1, buf, Zn(II) = (2.4 ± 0.2) × 107 M-1; Ka1, MeOH:buf, Co(II) = (3.4 ± 0.9) × 107
M-1 and Ka1,

MeOH:buf, Zn(II) =

(2.3 ± 0.6) × 107 M-1) (Table 2.8).59 For the second BPA

binding, Co2+ exhibited a 28- and 29-fold stronger affinity (in buffer and MeOH:buffer
mixture, respectively) than Zn2+ (Ka2, buf, Co(II) = (2.0 ± 0.3) × 105 M-1 and Ka2, buf, Zn(II) = (7
± 3) × 103 M-1); Ka2, MeOH:buf, Co(II) = (2.3 ± 0.6) × 105 M-1 and Ka2, MeOH:buf, Zn(II) = (7 ± 7) ×
103 M-1) (Table 2.8).70 Co2+ thus exhibited a less drastic reduction in affinity for the
second BPA. This affinity reduction for either metal ion can be explained by the ligand
field theory in that filling electrons from the first BPA yields more energy stabilization
than filling electrons from the second BPA. Given the d orbital electron configurations of
Co2+ (d7) and Zn2+ (d10), adding the sixth (for Co2+) and the 5th (for Zn2+) pair of ligand
electrons tend to raise the energy of the complex, thus explaining the drastic difference
between Co2+ and Zn2+ in bonding the second BPA. These results are consistent with the
fact that Zn2+ prefers to form 4- or 5- coordination tetrahedral or trigonal bipyramidal
complex while Co2+ in addition also forms 6-coordination octahedral complexes. The
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Co2+-(BPA)2 and Zn2+-(BPA)2 complexes therefore differ not only in the affinity of the
second BPA but likely the number of coordination bonds with the second BPA thus the
geometry of the resulting complex.
No Co2+-(BPA)2 complexes have been reported in solution or in crystal form. But
complexes of Co2+-BPA plus ancillary ligands have been reported such as
[Co2+(BPA)(NO2)Cl]

obtained

in

the

presence

of

1:1:1:1

molar

ratio

of

Co2+:BPA:NO2:Cl-.82 Given that Co2+-(BPA)2 complex was observed in the presence of
excess amount of BPA and that the second BPA binds with much weaker affinity. Finally,
no dioxygen binding has been report for Co2+-BPA. There was no indication of dioxygen
binding in the ITC data either.
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a)

c)

b)

d)

Figure 2.14 Raw data (top panel) and binding isotherm (bottom panel) for titrations a) 4.5 mM BPA into
0.3 mM CoCl2 in NEM buffer, pH 6.80. b) 1.5 mM BPA into 0.05 mM CoCl2 in NEM buffer, pH 7.25. c)
1 mM BPA into 0.05 mM CoCl2 in 60:40 (by volume) mixture of MeOH:NEM buffer, pH 6.80. d) 1 mM
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BPA into 0.05 mM CoCl2 in 60:40 (by volume) mixture of MeOH:NEM buffer, pH 7.25. All at 25 C.

BPA had approximately equal binding affinity for the first BPA binding in NEM buffer
pH 6.80 and pH 7.25 (Ka1, Co(BPA) = (3.4 ± 2.6) × 107 M-1and Ka1, Co(BPA) = (2.9 ± 0.9) × 107 M-1
in NEM buffer pH 6.80 and pH 7.25, respectively). BPA had a 5-fold decrease in binding affinity
for the second BPA(Co) binding in NEM buffer pH 6.80 and pH 7.25 (Ka2, Co(BPA) = (1.8 ± 0.1) ×
105 M-1 and Ka2,

Co(BPA)

= (3.2 ± 0.5) × 104 M-1 in NEM buffer pH 6.80 and pH 7.25,

respectively). No data is available for BPAbinding in MeOH:buffer pH 6.80, therefore, no
comparison can be made based on pH changes. Co2+ behaved similarly as Zn2+ does in their
interaction with BPA in NEM buffer pH 6.80. Both formed a 1:1 ML binary complex with an
affinity that is the same within error (Ka1, Zn(BPA) = (2.4 ± 0.2) × 107 M-1 and Ka1, Co(BPA) = (3.4 ±
2.6) × 107 M-1 in NEM buffer at pH 6.80). However, the second binding affinity was 2.5 fold
stronger for Co:BPA compared to Zn:BPA (Ka2, Zn(BPA) = (7 ± 3) × 103 M-1
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and Ka2, Co(BPA) =

(1.8 ± 0.1) × 105 M-1 in NEM buffer pH 6.80).
Table 2.8 Thermodynamic parameters from ITC study of BPA interaction with Co2+ in 60:40
(by volume) mixture of MeOH:NEM buffer pH (6.80 and 7.25).*
Medium

pH

n
(BPA/Co2+
)
1st BPA
2nd BPA
1st BPA
2nd BPA

Ka
(M-1)

Kd
(μM)

ΔG°
(kcal/mol)

ΔH°
(kcal/mol)

TΔS°
(kcal/mol)

NEM Buffer

6.80

(5.6 ± 0.8) × 107
(2.0 ± 0.3) × 105
(4.6 ± 0.6) × 107
(2.69 ± 0.06) × 105

0.018 ± 0.002
5.1 ± 0.7
0.022 ± 0.003
3.72 ± 0.08

-10.6 ± 0.1
-7.2 ± 0.1
-10.45 ± 0.01
-7.41 ± 0.01

-10.3 ± 0.1
-7.8 ± 0.3
-8.84 ± 0.03
-6.6 ± 0.3

0.7 ± 0.5
0.2 ± 0.3
1.2 ± 0.2
0.1 ± 0.4

6.80

1st BPA
2nd BPA

(3.6 ± 0.9) × 107
(2.0 ± 0.4) × 105

0.029 ± 0.007
5.2 ± 1.0

-10.3 ± 0.1
-7.2 ± 0.1

-9.0 ± 0.1
-6.0 ± 0.3

1.29 ± 0.08
1.3 ± 0.3

7.25

1st BPA

(7.0 ± 0.3) × 107

0.0142 ± 0.0005

-10.70 ± 0.02

-9.11 ± 0.09

1.6 ± 0.1

7.25
MeOH:NEM
Buffer

nd



5

2 BPA
(2.5 ± 0.1) × 10
(4.0 ± 0.2)
-7.36 ± 0.03
-6.9 ± 0.1
0.4 ± 0.1
Titrations of 1 mM BPA into 0.05 mM Co2+ in MeOH:NEM buffer at both pHs, 1.5 mM BPA into 0.05 mM Co2+ in NEM buffer
only at both pHs . In all cases, the ligand was titrated into the CoCl2 solution. *Two BPA molecules were bound per Co2+ thus
two sets of binding parameters derived from a sequential binding site model are shown. All parameters were averages from at
least three experiments. Ka and Kd refer to the pH-dependent conditional equilibrium association and dissociation constant,
respectively, for an equilibrium including ligand deprotonation, buffer protonation and ligand coordination to Co 2+. The values of
G, H and TS were for per mole of ligand for the overall equilibrium.
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2.3 ITC Studies of the Interactions of Ligands with Mn2+
2.3.1 Tris(2-aminoethyl)amine (TREN) interaction with Mn2+
Complexation of TREN with Mn2+ have been studied by Schaefer et al using X-ray
crystallography.83 Mn2+ is found to coordinate to two TREN molecules, forming an
octahedral complex.83 In our work, the interaction of TREN with Mn 2+ was studied in
MeOH: NEM buffer mixture at pH 6.80. A solution of TREN was titrated into MnCl2 and
a corresponding control experiment of TREN titration into MeOH:buffer mixture was
also performed. The control heat which corresponded to the dilution of TREN was
subtracted from the heat of TREN into MnCl2 titration to remove heat not
stoichiometrically correlated with the TREN-Mn2+ binding event (Figure 2.15). The
control-subtracted binding isotherms showed endothermic binding and fitted well to a
one-set-of-sites binding model (Figure 2.16). The fit yielded a stoichiometric ratio of one
TREN per Mn2+, indicating the formation of a 1:1 (Mn2+:TREN) binary complex (Table
2.9). As manganese is capable of six coordination bonds and Mn(TREN) 2 complex has
been observed84,85, future experiments could use higher titrant and titrate concentrations
to determine if a weak second TREN binding can be observed in ITC. It should be
pointed out that the Mn2+-TREN binding heat was small, even smaller than the TREN
dilution heat, greatly limiting data reliability. An alternative method such as UV-Vis can
be used to confirm the binding parameters from ITC.
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Figure 2.15. Raw data (top panel) and binding isotherm (bottom panel) for titrations of 10 mM
TREN into 1 mM MnCl2 in 60:40 (by volume) mixture of MeOH:NEM buffer pH 6.80, 25 C.
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Figure 2.16. Raw data (top panel) and binding isotherm (bottom panel) for titrations of 10 mM
TREN into 1 mM MnCl2 in 60:40 (by volume) mixture of MeOH:NEM buffer, pH 6.80, 25C.
after subtract the control run of 0.5 mM TREN into MeOH:NEM buffer, pH 6.80, 25 C.
When a reverse order titration was performed, i.e., when MnCl2 (10 mM) was titrated into TREN
(1 mM) in the same solution condition, no binding was detected (Figure 2.17). The differences
could be due to different availability of titrant and titrate in the two injection orders, although
this could not fully explain the lack of binding. Additional experiments are needed to resolve the
discrepancy.
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Figure 2.17. Overlay of binding isotherms for MnCl2 titrated into TREN in 60:40 (by volume) mixture of MeOH:
50 mM NEM buffer (pH 6.80, at 25C) experiment and the control experiment of MnCl2 titration into the same
buffer condition.

Table 2.9. Thermodynamic parameters of TREN interaction with Mn2+ in 60:40 (by volume)
mixture of MeOH: NEM buffer at pH 6.80.*

Before subtract
control heat
After subtract
control heat

n
(TREN/Mn2+)

Ka
(M-1)

Kd
(μM)

ΔG°
(kcal/mol)

ΔH°
(kcal/mol)

TΔS°
(kcal/mol)

0.93

1.04 ×104

96.2

-5.48

-0.18

5.3

0.78

4.04 ×104

24.8

-6.28

0.38

6.6

*Titrations of 10 mM TREN into 1 mM Mn2+. The value was from only one experiment.

2.3.2 Tris(2-pyridylmethyl)amine (TPA) interaction with Mn2+
TPA was titrated into MnCl2 in the MeOH:NEM mixture at pH 6.80. The resulting
binding isotherms were fit to a one-set-of-sites binding model (Figure 2.18). Curve fitting
yielded an affinity constant of (4.6 ± 0.3) ×105 M-1 (Figure 2.18 and Table 2.10). TPA and
Mn2+ formed a binary complex as suggested by the stoichiometric ratio of 1 TPA per
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Mn2+ (Table 2.10). Therefore Mn2+ behaved similarly as other two metal ions, Cu2+ and
Co2+, in forming a binary complex with TPA but differ in the affinity, with Mn2+ having
the weakest affinity of the three metal ions.

Figure 2.18. Raw data (top panel) and binding isotherm (bottom panel) for titrations of 0.75 mM
TPA into 0.075 mM MnCl2 in 60:40 (by volume) mixture of MeOH: 50 mM NEM buffer (0.150
M NaCl, pH 6.80) at 25 C.
Table 2.10 Thermodynamic parameters from ITC study of TPA interaction with Mn2+ in
MeOH:NEM buffer, pH 6.80*
n (TPA/Mn2+)
0.97 ± 0.02

Ka
(M-1)
(4.6 ± 0.3) × 105

Kd
(μM)
2.1 ± 0.2

ΔG°
(kcal/mol)
-7.74 ± 0.04

*Titrations of 0.75 mM TPA into 0.075 mM Mn2+
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ΔH°
(kcal/mol)
-3.5 ± 0.0

TΔS°
(kcal/mol)
4.21 ± 0.04

2.3.3 Bis(2-picolyl)amine (BPA) interaction with Mn2+
BPA was soluble in both the NEM buffer and in MeOH: NEM buffer mixture at pH 6.8.
In this study we examined the interaction in the MeOH:NEM mixture only, because our
immediate goal was to study the interaction of the resulting binary complex with 8-HQ which is
soluble only in the MeOH:buffer mixture. When 10 mM of BPA was titrated into 1 mM MnCl2
the resulting binding isotherm was fit to a one-set-of-sites binding model (Figure 2.19) which
yielded an apparent affinity constant (Ka) of (1.3 ± 0.1) x104 M-1 and a stoichiometric ratio of
0.99 ± 0.04 BPA per Mn2+, corresponding to a 1:1 (BPA: Mn2+) binary complex (Table 2.11).
This stoichiometric ratio met the requirement for a 1:1 binary complex for it to serve as an
enzyme active site copper structural mimetic. Although we did not observe the binding of a
second BPA, Glerup et al. reported a [Mn(BPA)2](ClO4)2 crystal structure showing Mn2+ bound
to two BPA molecules.86 The absence of a second BPA binding in ITC may be explained by the
different anions used, i.e. Cl- in the ITC study versus the ClO4- in the crystallographic study.
Chloride ion is known to have an affinity for divalent metal ions therefore compete with BPA for
Mn2+ binding while ClO4- does not. Additionally, the second BPA likely binds Mn2+ with orders
of magnitude weaker affinity than the first BPA, as was true for Co2+ and has also been reported
for Zn2+.59 Given that Mn2+ bound the first BPA significantly weaker (Ka = (1.3 ± 0.1) x104)
than Co2+ (Ka = (3.6 ± 0.9) × 107 M-1), it is possible that the second BPA binds Mn2+ too weakly
to be detected at the concentration (1 mM Mn2+) used in the ITC experiment.
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Figure 2.19. Raw data (top panel) and binding isotherm (bottom panel) for titrations of 10 mM
BPA into 1 mM MnCl2 in 60:40 (by volume) mixture of MeOH: 50 mM NEM buffer (0.150 M
NaCl, pH 6.80) at 25 C.
Table 2.11 Thermodynamic parameters from ITC study of BPA interaction with Mn2+ in 60:40
(by volume) mixture of MeOH: 50 mM NEM buffer (0.150 M NaCl, pH 6.80).*
n
(BPA/Mn2+)
0.99 ± 0.04

Ka
(M-1)
(1.3 ± 0.1) x104

Kd
(μM)
78.5 ± 9.9

ΔG°
(kcal/mol)
-5.60 ± 0.08

ΔH°
(kcal/mol)
-2.54± 0.04

TΔS°
(kcal/mol)
3.06 ± 0.12

*Titrations of 10 mM BPA into 1 mM Mn2+

Chapter 3: ITC studies of the interactions of potential enzyme active site metal ion(II)
structural mimetics with inhibitors
The first goal of this project was to examine the potential of five ligands in forming an
enzyme active site metal ion (II) structural mimetics. Three of the ligands, BPA, TPA, and
TREN, were selected for further ITC studies to examine their interaction with 8-HQ, given their
shared solubility with 8-HQ in the MeOH: buffer mixture as well as their strong affinities for the
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metal ions (II) and/or their favorable 1:1 M2+:ligand stoichiometric ratio in the resulting
complex. An ideal enzyme active site metal ion (II) structural mimetic would be formed with a
ligand that has a very high affinity (Ka ≥ 105 M-1) for the divalent metal ion and forms strong ML
binary complex while still leaving adequate coordination sites for an inhibitor binding. The
inhibitor selected for ITC study of the interaction with the enzyme active site metal ion (II)
structural mimetics was 8-hydroxyquinoline (8-HQ).
3. 8-Hydroxyquinoline (8-HQ) interaction with ligand-metal ion (II) mixtures as potential
enzyme active site metal ion(II) structural mimetics
ITC experiments were done to study the interaction between 8-HQ and various ML binary
complexes that had been identified as potential enzyme active site metal ion(M2+) structural
mimetics in the previous section based on the ITC studies of ligand and M2+ interactions. The
three different binary systems were selected which include M(TPA), M(BPA), and M(TREN).
Experiments were performed by titrating 8-HQ solution into a solution of ML complex in
MeOH:buffer (60:40 by volume) mixture (buffer being 50 mM Tris or NEM, 0.15 M NaCl) at
pH 6.80 or 7.40.

3.1. ITC studies of the interactions of 8-HQ with Cu2+L Complexes
Given that all three ligands formed a strong Cu2+L binary complex in the MeOH:Tris
buffer mixture, we examined the interaction of each of the three binary complexes with 8-HQ, a
known metalloenzyme active site inhibitor in the solvent mixture at pH 7.4. 8-HQ was chosen as
it is a known inhibitor for copper-metalloenzymes active site88 and it exhibits metal chelation
affinities that can be accurately determined using ITC. The MeOH:Tris buffer mixture was
chosen to solubilize 8-HQ and TPA which are otherwise insoluble in buffer. If a ML binary
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complex is able to bind one 8-HQ without losing the bound ligand thereby forming a Cu2+L(8HQ) ternary complex, it would in effect serve as an enzyme active site Cu2+ structural mimetic.
The G for the inhibitor interaction with the binary complex provides an estimation of the
Gibbs free energy contribution of Cu2+ to the overall inhibitor enzyme active site interactions.
3.1.1. TREN-Cu2+ interaction with 8-Hydroxyquinoline
As stated in chapter 2, TREN was determined to bind Cu2+ in a 1:1 stoichiometric ratio
and had a stronger affinity for Cu2+ in MeOH:Tris buffer than in Tris buffer. ITC experiments for
8-HQ binding to the Cu(TREN) binary complex were done with a mixture of TREN and CuCl2
at 1.05:1 (TREN:Cu2+) molar ratio to ensure that no free Cu2+ existed and that if 8-HQ binding
was indeed observed, it was binding to Cu(TREN) complex rather than free Cu2+. Fitting of the
binding isotherm to a one set of sites model (Figure 3.1) yielded an n value of 2.68 ± 0.03
(approx. 3) 8-HQ per Cu2+(Table 3.1), This suggests that 8-HQ had displaced the TREN and has
formed a [Cu(8-HQ)3]-2 complex instead of a Cu(TREN)(8-HQ) ternary complex. The binding
curve also suggests that the three 8-HQ molecules bound with the same affinity to Cu2+ with Ka
of (2.8 ± 0.1) x104 M-1. This affinity of 8-HQ for Cu2+-TREN was much smaller than that for
free Cu2+ (Ka=(3.24 ± 2.76) × 106 M-1). This can be explained by the presence of TREN which
competes with 8-HQ for Cu2+ binding. The formation of a Cu(8-HQ)3 complex also indicates
that this complex was more stable than a Cu(TREN((8-HQ) ternary complex. The inability in
forming a Cu(TREN((8-HQ) ternary complex makes Cu(TREN) unsuitable as an enzyme active
site copper ion structural mimetic.
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Figure 3.1 Raw data (top panel) and binding isotherm (bottom panel) for titration of 4 mM 8hydroxyquinoline into a solution containing 0.2 mM CuCl2 and 0.21 mM TREN in 60:40 (by
volume) mixture of MeOH: 50 mM Tris Buffer (0.150 M NaCl) at pH 7.40 at 25 °C
Table 3.1 Thermodynamic parameters from ITC study of 8-hydroxyquinoline into a solution
containing CuCl2 and TREN at 25 C
n
2.68 ± 0.00

Ka
(M-1)
(2.8 ± 0.1) x104

Kd
(μM)
35 ± 1

ΔG°
(kcal/mol)
-6.02 ± 0.02

ΔH°
(kcal/mol)
-4.38 ± 0.05

TΔS°
(kcal/mol)
1.7 ± 0.1

*Titrations of 8 mM 8-HQ into 0.2 mM CuCl2 and 0.2 mM TREN in MeOH:Tris buffer.

3.1.2 Cu(TPA) interaction with 8-Hydroxyquinoline
In Chapter 2, TPA was determined to form a 1:1 binary complex with Cu2+ in MeOH:Tris
buffer with a strong affinity for Cu2+. ITC experiments for 8-HQ binding to the Cu(TPA) binary
complex were done by titrating 8-HQ into a mixture of TPA and CuCl2 at 1.2:1 (TPA:Cu2+)
molar ratio which was the result of injecting TPA into Cu2+ chapter 2 and also to ensure that no
free Cu2+ existed and that if 8-HQ binding was indeed observed, it was binding to Cu(TPA)
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complex rather than free Cu2+. When the ITC data from the 8-HQ into Cu2+-TPA binary complex
was analyzed, the n value was determined by using sequential binding model with n of 2, i.e.,
two 8-HQ sequentially bind each Cu2+ and therefore have different affinities as evidenced by the
shape of the curve. The binding isotherm (Figure 3.2) showed an initial downward region
followed by an upward region. The Ka1 and Ka2 values were (2.0 ± 1.3) x103 and (5.9 ± 1.8) x104
M-1, respectively (Table 3.2). These observed Ka values were much smaller than that for 8-HQ
binding to free Cu2+ ((3.24 ± 2.76) × 106 M-1) because of the competition of TPA (Figure 3.2).
Given that free Cu2+ also bound to two 8-HQ, we believe that TPA was displaced by 8-HQ and
no Cu(TPA)(8-HQ) complex was formed. Therefore, TPA is not an acceptable ligand to create
an enzyme active site copper ion structural mimetic.

Figure 3.2 Raw data (top panel) and binding isotherm (bottom panel) for titration of 8 mM 8hydroxyquinoline into a solution containing 0.2 mM CuCl2 and 0.24 mM TPA in 60:40 (by
volume) mixture of MeOH: 50 mM Tris Buffer (0.150 M NaCl) at pH 7.40 at 25°C
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Table 3.2 Thermodynamic parameters from ITC study of 8-hydroxyquinoline into a solution
containing CuCl2 and TPA
Ka
Kd
ΔG°
ΔH°
(M-1)
(μM)
(kcal/mol)
(kcal/mol)
2 (sequential) (2.0 ± 1.3) × 103 (6.4 ± 4.2) ×102
-4.4 ± 0.4
39.7 ± 4.5
(5.9 ± 1.1) × 104
17.9 ± 0.3
-6.5 ± 0.2
47.5 ± 7.9
*Titrations of 8 mM 8-HQ into 0.2 mM CuCl2 and 0.24 mM TPA in MeOH:Tris buffer.
n

TΔS°
(kcal/mol)
43.4 ± 4.0
41.0 ± 6.8

3.1.3. Cu(BPA) interaction with 8-Hydroxyquinoline
Titrations of 8-HQ into Cu2+-BPA mixture were done with varying ratios of BPA to Cu2+.
As shown in chapter 2, the BPA into Cu2+ titration experiments revealed two BPA molecules
binding each Cu2+, with the first BPA binding Cu2+ with high affinity (Ka = (1.8±1.0) x105 M-1)
and the second BPA binding two-times weaker (Ka = (5.0±4.2) x103 M-1) than the first BPA
(Table 2.5). Although this was not an ideal mimetic system, since the second BPA binds very
weakly, it was hypothesized that an inhibitor (such as 8-HQ) would be capable of displacing the
second BPA in binding to Cu2+.
To avoid the issue of 8-HQ competing off the second BPA molecule, 1:1 binding was
forced by making the Cu(BPA) complex using a 1:1 molar ratio of (BPA:Cu2+). The raw ITC
data did not show signs of the weakly bound BPA being displaced by 8-HQ, nor did it show
signs of 8-HQ binding free rather than BPA-complexed Cu2+ (Figure 3.3) since the n value
differed from the n value obtained for the titration of 8-HQ titration into free Cu2+ (n = 2.0 ± 0.3)
(Table 4.1, Chapter 4).
Titrations of 8-HQ into 2:1 (BPA:Cu2+) solutions were also performed (Figure 3.4),
which yielded an n value of 1.03 ± 0.01 (Table 3.3). The decreasing n value with the increasing
ratios of BPA:Cu2+ reflects the decreasing presence of the Cu(BPA) complex but increasing
presence of the Cu(BPA)2 complex over the 1:1 (BPA:Cu2+) complex. It also suggests that not all
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Cu2+ were bound with two BPA molecules at the 2:1 (BPA:Cu2+) ratio despite twice as much
BPA as Cu2+ was present, which can be explained by the weak affinity of the second BPA
molecule. As the ratio of BPA:Cu2+ increased from 1:1 to 2:1, the Ka value for 8-HQ binding
also decreased, specifically by approximately 5-fold from (2.0 ± 0.4) × 105 M-1 to (3.9 ± 0.3) ×
104 M-1. This decrease of affinity was likely due to the competition of the free BPA in the
solution.
To conclude, for the BPA to be used as an potential enzyme active site copper ion
structural mimetic, a 1:1 ratio of BPA:Cu2+ was necessary and sufficient for creating a stable 1:1
complex capable of coordinating to one molecule of 8-HQ.

Figure 3.3 Raw data (top panel) and binding isotherm (bottom panel) for titration of 5 mM 8hydroxyquinoline into a solution containing 0.5 mM CuCl2 and 0.5 mM BPA (1:1) in 60:40 (by
volume) mixture of MeOH: 50 mM Tris Buffer (0.150 M NaCl) at pH 7.40 at 25 °C
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Figure 3.4 Raw data (top panel) and binding isotherm (bottom panel) for titration of 10 mM 8hydroxyquinoline into a solution containing 1 mM CuCl2 and 2 mM BPA (1:2) in 60:40 (by
volume) mixture of MeOH: 50 mM Tris Buffer (0.150 M NaCl) at pH 7.40 at 25 °C
Table 3.3. Thermodynamic parameters from ITC studies of 8-HQ interaction with Cu2+:BPA at
25 C in the MeOH: Tris buffer mixture at pH 7.4.
Ratio of
(BPA/Cu2+)
1:1

n
1.18 ± 0.01

2:1

1.03 ± 0.01

Ka
(M-1)
(2.02 ± 0.4) ×
105
(3.9 ± 0.3) × 104

Kd
(μM)
5.0 ± 0.1

ΔG°
(kcal/mol)
-7.24 ± 0.01

2.6 ± 0.2

-6.26 ± 0.05

ΔH°
(kcal/mol)
-11.4 ± 0.1

ΔS°
(cal/(mol·K))
-13.9±0.6

TΔS°
(kcal/mol)
-4.2 ± 0.2

-6.77
± -1.72 ±0.32
-0.51 ± 0.09
0.05
* Titrations of 10 mM 8-HQ into (0.5 mM Cu2+ and 1 mM BPA) in Tris buffer, titrations of 5 mM 8-HQ into (0.5
mM Cu2+ and 0.5 mM BPA) in MeOH:Tris buffer.

3.2. ITC studies of the interactions of 8-HQ with Co2+L Complexes
Given that all three ligands formed a strong Co2+L binary complex in the MeOH:buffer
mixture, we examined the interaction of each of the three binary complexes with 8-HQ, a known
metalloenzyme active site inhibitor in the solvent mixture at pH 6.80. The methanol:buffer
mixture was chosen to solubilize 8-HQ and TPA which were otherwise insoluble in buffer. Like
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copper, the interaction of 8-HQ, a known inhibitor for cobalt-metalloenzymes87, with cobalt can
be studied using ITC. Co2+ is reported to bind two molecules of 8-HQ.89 If a binary complex is
able to bind one 8-HQ without losing the bound ligand thereby forming a CoL(8-HQ) ternary
complex, it would in effect serve as an enzyme active site Co2+ structural mimetic. The G for
the inhibitor interaction with the binary complex provides an estimation of the Gibbs free energy
contribution of Co2+ to the overall inhibitor enzyme active site interactions.
3.2.1. Co2+(TREN) interaction with 8-Hydroxyquinoline
A mixture of TREN and CoCl2 at 1:1 (TREN:Co2+) molar ratio was formed and titrated
with 8-HQ in the methanol:buffer mixture at pH 6.80. Care was taken when choosing the exact
molar ratio of TREN and Co2+ so that no excess Co2+ was present in the mixture. If residual
amount of free TREN was present, it was not expected to affect the resulting binding parameters.
The observed binding curve (Figure 3.5), which corresponded to 8-HQ binding to the 1:1
(TREN:Co2+) complex, fitted well to a one-set-of-sites model. Curve fitting yielded a Ka,obs of
(2.0 ± 0.4) × 104 M-1 and an n value of 0.56 ± 0.08 8-HQ per TREN-associated Co2+ which
corresponded to one 8-HQ bound to two Co2+-TREN complexes. Given that ligand-free Co2+
binds two 8-HQ molecules89, this result suggests that TREN did not dissociate from Co2+ upon
titration of 8-HQ. Rather, two Co2+-TREN complexes bound to one 8-HQ. In light of the
tendency of Co2+ to form µ-peroxo-bridged dicobalt complexes with TREN, the current result
supports the idea that the 1:1 (TREN:Co2+) complex formed in methanol:buffer at pH 6.80 was
likely Co2(TREN)2(µ-O2). Therefore the complex formed with 8-HQ was likely Co2(TREN)2(µ8-HQ)(µ-O2). Such binding mode has also been reported for 5-pyrimidyl-tetrazolate (pmtz) in
the complex of [Co2(TREN)2(µ-pmtz)(µ-O2)](ClO4)3.90 In the crystal structure of this complex,
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the two Co2+-TREN complexes are bridged via a peroxo plus the two neighboring tetrazolate
nitrogens, forming a stable 6-membered ring. Alternatively, it was also possible that bridging of
the two Co2+-TREN complexes via the µ-peroxo bridge occurred simultaneously with 8-HQ
binding, although a less stable 8-membered ring would result. An alternative would be a
hydroxyl group bridging the two Co2+,65 forming a 7-membered ring. Two cobalt ions linked
through a hydroxyl group have also been reported in proteins.91,92 The exact binding mode as
well as the oxidation state of cobalt in the (Co2+)2(TREN)2(8-HQ) complex will have to wait for
further solution and crystallographic studies of the complex structure.

Figure 3.5. ITC titration raw data and binding isotherm for titrations of 10 mM 8-HQ into TREN
and CoCl2 mixture at 1 mM TREN and 1 mM Co2+ in the MeOH:buffer mixture, pH 6.80, at 25
C.

78

Dicobalt centers formed upon 8-HQ binding have biological counterparts. For example, the
bioremediator Glycerophosphodiesterase (GpdQ) from Enterobacter aerogenes, whose
enzymatic activity depends on Co2+ or other metal ions such as Zn2+, recruits the second metal
ion upon substrate binding to form a catalytically competent dimetal center.92 The crystal
structures of the Co2+- and Zn2+- substituted GpdQ reveal that a hydroxyl group or a water
molecule bridges the two metal ions.93,94 Product dissociation returns the enzyme to a
catalytically inactive mononuclear state. Other examples of enzymes that is activated to bind a
second metal ion upon substrate binding include enolase95 and S-adenosylmethionine synthase.96
The current (Co2+)2(TREN)2 complex can therefore serve as a structural mimetic for dicobalt
centers at such an enzyme active site.
Unlike for Co2+-TREN, Zn2+-TREN interaction with 8-HQ leads to displacement
of TREN and formation of a Zn2+-(8-HQ)2 complex.59 The current ITC data on Co2+
interacting with TREN and the binary complex interacting with 8-HQ indicate that Co2+
was more prone than Zn2+ to forming dinuclear centers upon interaction with small
molecule ligand and inhibitor. The affinity constant of Co2+-TREN for 8-HQ in forming
the (Co2+)2(TREN)2(8-HQ) complex corresponded to a G value of -5.9 ± 0.1 kcal/mol
8-HQ. In light of the potential involvement of a dioxygen bridge and the uncertainty in
the sequence of event in µ-O2 and µ-8-HQ bridge formation, this value can be taken only
as a very rough estimate for the free energy contribution of a dicobalt center to the overall
interaction of a dicobalt-containing active site interaction with 8-HQ.
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3.2.2. Co2+(TPA) interaction with 8-Hydroxyquinoline
A mixture of TPA and CoCl2 at 1:1 (TPA:Co2+) molar ratio was formed and titrated with
8-HQ in the methanol:buffer mixture at pH 6.80. Care was taken when choosing the exact molar
ratio of TPA and Co2+ so that no excess Co2+ was present in the mixture. If residual free TPA
was present, it was not expected to alter binding parameters. The observed binding curve (Figure
3.6) corresponded to 8-HQ binding to the Co2+-TPA complex and fitted well to a one-set-of-sites
model. Curve fitting yielded an n value of 1.08 ± 0.01 8-HQ per TPA-associated Co2+,
corresponding to the formation of a Co2+-TPA-(8-HQ) ternary complex, and a Ka,obs value of
(1.37 ± 0.03) × 104 M-1. The G value of -5.64 ± 0.01 kcal per mole of 8-HQ provided an
estimate of the energetic contribution of an active site Co2+ to the overall G for 8-HQ binding
to a Co2+-containing enzyme active site (Table 3.4). This result indirectly points to the absence
of dioxygen binding of Co2+-TPA complex. Unlike Co2+-TPA, a similar Zn2+-TPA binary
complex does not bind 8-HQ.59 This difference between Co2+ and Zn2+ can be attributed to the d7
(Co2+) and d10 (Zn2+) electron configuration which predicts favorable and unfavorable free
energy change for Co2+-TPA and Zn2+-TPA, respectively, in forming two additional coordination
bonds to bind 8-HQ. Therefore Co2+-TPA successfully served as an active site Co2+ mimetic
while Zn2+-TPA does not. This suggests that an active site 4-coordinated Co2+ ion can be
expected to contribute to the active site interaction with a substrate or inhibitor more
significantly than a 4-coordinated Zn2+ does.
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Figure 3.6 ITC titration raw data and binding isotherm for titrations of 10 mM 8-HQ into
TPA and CoCl2 mixture at 1 mM TPA and 1 mM Co2+ in the MeOH:buffer mixture, pH
6.80, at 25 C.
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3.2.3. Co2+(BPA) interaction with 8-Hydroxyquinoline
BPA formed a strong Co2+-BPA binary complex. In addition, the binary complex also
bound a second BPA but with 2-orders of magnitude weaker affinity. Mixing BPA and CoCl2 at
1:1 (BPA :Co2+) molar ratio at sub-milimolar concentrations helped form the Co2+-BPA binary
complex without a significant presence of the Co2+-(BPA)2 ternary complex. 8-HQ was titrated
into the binary complex prepared using freshly made CoCl2 solution in the methanol:buffer
mixture at pH 6.80. The observed binding curve (Figure 3.7) fitted well to a one-set-of-sites
model, which yielded an n value of 0.94 ± 0.10 8-HQ per BPA-bound Co2+, indicating the
formation of a Co2+-BPA-8-HQ ternary complex. The affinity constant of 8-HQ for Co2+-BPA
was (2.0 ± 0.7) × 106 M-1 and the corresponding G value was -8.6 ± 0.2 kcal per mole of 8-HQ
(Table 3.4). This G value provided an estimate for the energetic contribution of an active site
Co2+ to the overall G of 8-HQ binding to a Co2+-containing enzyme active site.
Surprisingly, Co2+-BPA bound 8-HQ over 100-fold more strongly than Zn2+-BPA does.59
This corresponded to 2.9 kcal/mol additional energy stabilization for Co2+-BPA over Zn2+BPA as the metal ion forms its 4th and 5th coordination bonds upon 8-HQ binding. This
large difference can be attributed to the different d orbital electron configuration as
discussed above for Co2+-TPA. Given this difference, an enzyme with its active site Zn 2+
replaced by Co2+, assuming with no coupled structural changes, can be expected to bind
its substrate or inhibitor 100-fold more strongly than the zinc enzyme. Additionally, Co2+BPA bound 8-HQ nearly two-orders of magnitude more strongly than Co2+-TPA did. This
suggests that a Co2+ ion that is three-coordinated to the enzyme active site residues will
contribute over 100-fold more significantly to the substrate or inhibitor affinity for the active site
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than a 4-coordinated active site Co2+ assuming there is no structural difference between the two
scenarios.

Figure 3.7 ITC titration raw data and binding isotherm for titrations of 3 mM 8-HQ into BPA
and CoCl2 at 0.3 mM BPA and 0.3 mM mM Co2+ in the MeOH:buffer mixture, pH 6.80, at 25
C.

Table 3.4 Thermodynamic parameters from ITC studies of 8-HQ interaction with Co2+:Ligand at
25 C in the MeOH:NEM buffer mixture at pH 6.80.
Co(Ligand)
(in calorimeter
cell)
[Co(TREN)]2+

n
(8-HQ :
CoL)
0.56 ± 0.08

[Co(TPA)]2+

1.08 ± 0.01

[Co(BPA)]2+

0.94 ± 0.10

ΔG°
(kcal/mol)

ΔH°
(kcal/mol)

ΔS°
(cal/(mol·K))

Ka
(M-1)

Kd
(μM)

(2.0 ± 0.4) × 104

50 ± 10

-5.9 ± 0.1

-11.5 ± 1.1

-5.6 ± 1.0

(1.37± 0.03) ×
104
(2.0 ± 0.7) × 106

73 ± 2

-5.64 ± 0.01

-10.32 ± 0.06

-4.67 ± 0.06

0.5 ± 2

-8.6 ± 0.2

-24.2 ± 0.8

-15.6 ± 0.7

Data were obtained from titrations of 8-HQ into a mixture of a ligand (TREN or TPA or BPA) and CoCl 2
(at 1:1 molar ratio of Ligand: Co 2+) in the MeOH:buffer (60:40 by volume) mixture at pH 6.80. The values
of G, H and TS were for per mole of Co2+ for an overall equilibrium of ligand-bound Co2+ coordinating to 8HQ coupled to any deprotonation and protonation reactions.
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3.3. ITC studies of the interactions of 8-HQ with MnL
Given that all three ligands formed a strong Mn2+L binary complex in the
methanol:buffer mixture, we examined the interaction of each of the three binary complexes with
8-HQ, a known metalloenzyme active site inhibitor in the solvent mixture at pH 6.80. The
methanol:buffer mixture was chosen to solubilize 8-HQ and TPA which are otherwise insoluble
in buffer. Mn2+ is reported to bind two molecules of 8-HQ in the presence of excess 8-HQ.88 If a
binary complex is able to bind one 8-HQ without losing the bound ligand thus forming a
Mn2+L(8-HQ) ternary complex, it would in effect serve as an enzyme active site Mn2+ structural
mimetic. The G for the inhibitor interaction with the binary complex provides an estimation of
the Gibbs free energy contribution of Mn2+ to the overall inhibitor enzyme active site
interactions.
3.3.1. Mn2+(TREN) interaction with 8-Hydroxyquinoline
As determined previously TREN and MnCl2 formed a Mn(TREN) binary complex.
Therefore, a mixture of 1:1 (TREN:Mn2+) in molar ratio was titrated with 8-HQ in the
MeOH:buffer mixture at pH 6.80. The binding isotherm was fit to a one set of sites model
(Figure 3.8), which yielded an n value of 1.53 ± 0.08 and a Ka value (5.98 ± 0.03) × 103 M-1
(Table 3.5). This result point to the formation of a Mn(8-HQ)2 rather than a Mn(TREN)(8-HQ)
ternary complex. This suggests that Mn(8-HQ)2 complex was more stable than the
Mn(TREN)(8-HQ) complex. The same was observed for the corresponding complexes for Cu2+
and Zn2+ but not Co2+
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As reported in Section 3.2.1, Co(TREN) interaction with 8-HQ yielded a complex of 8-HQ
bonding to two copies of Co(TREN). Such a complex likely was facilitated by a µ-peroxo
linkage therefore the complex was likely Co2(TREN)2(µ-8-HQ)(µ-O2). TREN in Co(TREN) was
therefore not displaced by 8-HQ, unlike for the other three metal ions which formed M(8-HQ)2
complex instead.59 To conclude, the inability of forming a Mn(TREN)(8-HQ) ternary complex
makes Mn(TREN) unsuitable as an enzyme active site manganese ion structural mimetic.

Figure 3.8 ITC titration raw data and binding isotherm for titrations of 4 mM 8-HQ into 0.2
MnCl2 and 0.2 TREN in the MeOH:NEM buffer mixture, pH 6.80, at 25 C.
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3.3.2. Mn2+(TPA) interaction with 8-Hydroxyquinoline
In Chapter 2, TPA was determined to form a Mn(TPA) binary complex with a strong
affinity in MeOH:Tris mixture. ITC experiments for 8-HQ binding to the Mn2+(TPA) binary
complex were done with a mixture of TPA and MnCl2 at 1:1 TPA:Mn2+ molar ratio. The
observed binding curve (Figure 3.9) fitted well to a one-set-of-sites model, which yielded an n
value of 1.00 ± 0.05 8-HQ per TPA-bound Mn2+, indicating the formation of a Mn2+(TPA)(8HQ) ternary complex. The affinity constant of 8-HQ for Mn(TPA) was (1.3 ± 0.1) × 104 M-1 and
the corresponding G value was -5.6 ± 0.3 kcal per mole of 8-HQ (Table 3.5). This G value
provided an estimate for the energetic contribution of an active site Mn2+ to the overall G for
8-HQ binding to a Mn2+-containing enzyme active site.

Figure 3.9 ITC titration raw data and binding isotherm for titrations of 10 mM 8-HQ into 1 mM
MnCl2 with 1 mM TPA in the MeOH:NEM buffer mixture, pH 6.80, at 25 C.
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3.3.3. Mn2+(BPA) interaction with 8-Hydroxyquinoline
BPA was shown to form a Mn(BPA) binary complex in MeOH:Tris buffer mixture with a
Ka of (1.3 ± 0.1) × 104 M-1. A mixture of BPA and Mn2+ at 1:1 molar ratio was used to form a
Mn(BPA) binary complex and titrated with 8-HQ. The observed binding curve (Figure 3.10)
fitted well to a one-set-of-sites model, which yielded an n value of 0.79 ± 0.03 8-HQ per BPAbound Mn2+ (Table 3.5), indicating the formation of approximately a Mn2+(BPA)(8-HQ) ternary
complex. The corresponding calculated G value was -5.3 ± 0.2 kcal per mole of 8-HQ (Table
3.5). Note that only one experiment was performed and the standard deviation here was derived
from curve fitting. This G value provided a rough estimate for the energetic contribution of an
active site Mn2+ to the overall G of 8-HQ binding to a Mn2+-containing enzyme active site.
The affinity constant of 8-HQ binding Mn(BPA) was (7.4 ± 0.1) × 103 M-1, weaker than that of 8HQ binding to Mn2+(TPA) (Ka = (1.3± 0.3) × 104 M-1) (Table 3.5). This relative affinity was
unexpected since the Mn2+ in Mn(BPA) has three coordination bonds while in Mn(TPA) it has
four coordination bonds. Given the fact that Mn2+ (d5) prefers to form octahedral complexes97,
electrons from 8-HQ would be filling the lower energy orbitals in the case of Mn2+(BPA) than in
Mn(TPA). Alternatively, BPA-bound Mn2+ has a higher net positive charge than the TPA-bound
Mn2+ therefore is expected to bind 8-HQ more strongly than Mn(TPA). Further experiments are
needed to obtain more reliable data before a rationale is provided for the observed difference.
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Figure 3.10 ITC titration raw data and binding isotherm for titrations of 10 mM 8-HQ into 1 mM
MnCl2 and 1 mM BPA in the MeOH:NEM buffer mixture, pH 6.80, at 25 C.
Table 3.5 Thermodynamic parameters from ITC studies of 8-HQ interaction with Mn2+:Ligand
at 25 C in the MeOH:buffer mixture at pH 6.80.
Mn(Ligand)
(in calorimeter cell)
[Mn(TREN)]2+

n
(8-HQ : MnL)
1.53 ± 0.08

[Mn(TPA)]2+
[Mn(BPA)]2+

1.00 ± 0.05
0.79 ± 0.03

Ka
(M-1)
(5.98 ± 0.03) ×
103
(1.3 ± 0.1) × 104
(7.4 ± 0.1) × 103

Kd
(μM)
(1.8 ± 0.01) × 102

ΔG°
(kcal/mol)
-5.2 ± 0.3

ΔH
(kcal/mol)
-0.77 ± 0.004

TΔS°
(kcal/m)
4.40 ± 0.02

(7.4 ± 0.4) × 10
(1.5 ± 0.5) × 102

-5.6 ± 0.3
-5.3 ± 0.2

-0.50 ± 0.003
-1.5 ± 0.1

5.10 ± 0.03
3.7 ± 0.2

Data were obtained from titrations of 8-HQ into a mixture of a ligand (TREN or TPA or BPA) and MnCl 2
(at 1:1 molar ratio of Ligand: Mn 2+) in the MeOH:buffer (60:40 by volume) mixture at pH 6.80. The values
of G, H and TS were for per mole of Mn2+ for an overall equilibrium of ligand-bound Mn2+ coordinating to
8-HQ coupled to any deprotonation and protonation reactions. The value of TREN and TPA experiment only from
one experiment.
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Chapter 4: ITC studies of the interactions of metal ion(II) with inhibitor
4.1 ITC studies of the interactions of 8-HQ with metal ion(II)
Complexes of the first row transition metal ions with 8-HQ have been reported and their
stability constants follow the Irving-Williams series (Zn < Cu > Co > Fe > Mn) in that copper
complexes are the most stable while manganese complexes are the least stable. Both 2:1 and 1:1
complexes of the divalent transition metal ions with 8-HQ have been reported based on
crystallography, the former in the presence of excess 8-HQ and the latter in the presence of
excess metal ion.88 A crystal structure of Cu(8-HQ)2(H2O)2 with a distorted octahedral geometry
was reported by N. Okabe and H. Saishu.98
To understand the interaction of 8-HQ with the three transition metal ions in the absence
of the ligands being investigated, ITC experiments of 8-HQ titration into the chloride salt of each
of the metal ions, Cu2+, Co2+ and Mn2+ were performed in the MeOH:Tris buffer mixture at pH
7.40, MeOH:NEM buffer mixture at pH 7.25, and MeOH:NEM buffer mixture at pH 6.80,
respectively. In all three solutions, 8-HQ was titrated into the metal ion solution and therefore the
8-HQ was in excess at the end of the titration. The resulting binding isotherms were fit to a oneset-of-sites binding model for Cu2+ and Co2+ (Figures 4.1 and 4.2, respectively) and a sequential
binding model for Mn2+ (Figures 4.3). The binding curves suggested that the two 8-HQ
molecules bound with the same affinity to a given metal ion (Cu2+ and Co2+) (Table 4.1),
however with a different affinity in the Mn2+ case (Table 4.1). Indeed, the affinity of 8-HQ was
the highest for Cu2+ (Ka, Cu(8-HQ)2 = (3.2 ± 0.3) × 106 M-1), the lowest for Mn2+ (Ka1,Mn(8-HQ) = (1.0
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± 0.2) × 105 M-1

and Ka2,Mn(8-HQ) = (1.3 ± 0.1) × 104 M-1) and intermediate for Co2+ (Ka,Co(8-HQ)2 = (1.3

± 0.3) × 106 M-1)). Therefore, our ITC data confirms the relative stability of 8-HQ complexes
between Cu2+, Co2+, and Mn2+ in their affinity with 8-HQ as stated in the Irving-Williams series.
It should be noted that the data for the three metal ions were obtained at somewhat different pH
(7.4 or 7.25 or 6.8) with different buffer (Tris in the case of Cu2+ which would underestimates
affinity between metal ion and ligand; NEM for Co2+ and Mn2+), the general trend for the
stability of the 8-HQ complexes still held true.
In MeOH:Tris buffer, Cu2+ bound two copies of the metalloenzyme inhibitor 8-HQ with a
high apparent affinity (Ka) of (3.2 ± 0.3) × 106 M-1. Clearly, as presented in chapter 2, 8-HQ
bound Cu2+ 3-orders of magnitude more strongly than the second BPA did (5.0 ± 4.2) x103 M-1.
This suggests that an inhibitor with high affinity for Cu2+ such as 8-HQ would be able to displace
the weak BPA or possibly both BPA, resulting in the formation of a Cu(8-HQ)2 complex.
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4.1.1 Cu2+ interaction with 8-Hydroxyquinoline

Figure 4.1 Raw data (top panel) and binding isotherm (bottom panel) for titration of 1 mM 8Hydroxyquinoline into a solution containing 0.05 mM CuCl2 in MeOH:Tris buffer mixture at pH
7.40 at 25 °C
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4.1.2 Co2+ interaction with 8-Hydroxyquinoline

Figure 4.2 Raw data (top panel) and binding isotherm (bottom panel) for titration of 10 mM 8HQ into a solution containing 0.5 mM CoCl2 in MeOH:NEM buffer mixture at pH 7.25 at 25 °C
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4.1.3 Mn2+ interaction with 8-Hydroxyquinoline

Figure 4.3 Raw data (top panel) and binding isotherm (bottom panel) for titration of 2 mM 8Hydroxyquinoline into a solution containing 0.1 mM MnCl2 in MeOH:NEM buffer mixture at
pH 6.80 at 25 °C
Table 4.1 Thermodynamic parameters from ITC studies of 8-HQ interaction with Cu2+, Co2+ or
Mn2+ at 25 C in the MeOH:buffer mixture at pH 7.40 , 7.25 and 6.80, respectively.
Metal
Cu2+

n
(8-HQ : M)
2.0 ± 0.3

Co2+

1.95 ± 0.04

Mn2+

sequential
binding
model n=2

Ka
(M-1)
(3.2 ± 0.3) ×
106
(1.3 ± 0.3) ×
106
(1.0 ± 0.2) ×
105
(1.3 ± 0.1) ×
104

Kd
(μM)
5.7 ± 0.5

ΔG°
(kcal/mol)
-8.7 ± 0.6

ΔH
(kcal/mol)
-8.3 ± 2.1

ΔS°
(cal/(mol·K))
1.2 ± 0.1

0.8 ± 0.2

-8.3± 0.2

-10.5 ± 0.2

-7.5 ± 0.9

9.7 ± 0.1

-6.8 ± 0.1

-2.8 ± 1.0

13.3 ± 0.6

7.6 ± 0.3

-5.6 ± 0.1

-7.9 ± 1.8

-7.8 ± 0.6

Data were obtained from titrations of 8-HQ into a solution of CuCl 2, CoCl2, and MnCl2 in the MeOH:buffer
(60:40 by volume) mixture.
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Chapter 5: Experimental methods for Isothermal titration calorimetry (ITC)
5.1 Methods
ITC experiments were performed on a MicroCal VP-ITC unit (GE Healthcare) at 25 °C. The
injection syringe and calorimeter reaction cell were allowed to soak in detergent before each
experiment (10% Contrad detergent, 0.1 M EDTA). Then, rinse the syringe (30 mL), the reaction
and reference cells thoroughly used Milli-Q water, and the syringe was dried with air. Degassed
the sample before loading which prepared in buffer using a ThermoVac degassing station
(Malvern Instruments). Samples in the present of methanol was not degassed to avoid differential
evaporation of organic versus aqueous solvent thus significant change of solution composition.
Always filled the reference cell of the calorimeter with the buffer that was used to prepare the
samples.
Analysis of calorimetric data was performed using Origin 7.2 software that came with the
instrument. The baseline for the raw data (μcal versus second) was manually adjusted. The
integration of the area under each peak yields the heat associated with each injection, which is
automatically normalized to per mole of titrant. This normalized heat as a function of
titrant:titrate molar ratio gives rise to the binding isotherm. The heat generated or absorbed
during the binding interaction is directly related to the fraction of ligand bound. If a significant
control heat for the dilution of the titrant was observed, it was subtracted from the binding
isotherm. The binding isotherm was then fit to either a one-set-of-sites or two-sets-of-sites
binding model provided by the manufacturer in the Origin software. The fit was iterated to
achieve the lowest Chi-squared value. In some instances, it was necessary to subtract a constant
value corresponding to the plateau heat of a binding isotherm which is conventionally thought to
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be a better control than a control experiment of injecting the titrant into a solution minus the
titrate (often the buffer). A nonlinear least square approach (Levenberg-Marquardt algorithm) is
then used to determine the thermodynamic parameters for the interaction studied: n, Ka, ΔH°,
and ΔS°. The equilibrium association constant was used to calculate ΔG° for the reaction
(Equation 1).
𝛥𝐺 ∘ = −𝑅𝑇 × 𝑙𝑛(𝐾𝑎 )

(1)

The ΔH° determined from curve fitting and the calculated ΔG° values were used to calculate
TΔS° using Equation (2).
𝑇∆𝑆° = ∆𝐻° − ∆𝐺°

(2)

The dissociation constant (Kd) was calculated from the Ka using Equation (3).
1

𝐾𝑑 = 𝐾

(3)

𝑎

The parameters obtained from repeat runs were averaged and error propagation was done for the
parameters of each interaction studied.
5.2. Materials
5.2.1. General Considerations
Nitrilotriacetic acid (NTA, >99%), tris(2-pyridylmethyl)amine (TPA, >98.0%), tris(2aminoethyl)amine (TREN, >96%) and bis(2-pyridylmethyl)amine (BPA, >98.0%) were
purchased from TCI. Acetohydroxamic acid (AHA, >98%), N-ethylmorpholine (NEM, ≥ 99%)
and methanol (MeOH, >99.9%) were from Acros Organics. 8-HQ was from Sigma Aldrich. N(2-(1-methylimidazolyl)methyl)iminodiacetic acid (DA2Im) was synthesized according to the
literature.99 All Copper experiment solutions –except for BPA experiments were done in both
Tris and NEM buffer- were prepared gravimetrically in 50 mM Tris buffer containing 0.15 M
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NaCl (hereafter referred to as Tris buffer) or a 60:40 (by volume) mixture of MeOH:Tris buffer
(hereafter referred to as MeOH: Tris buffer mixture) using Milli-Q water (≥18.2 MΩ, Milli-Q
integral water purification system, Millipore), to a final pH of 7.40 ± 0.02. All cobalt and
manganese experiment solutions were prepared gravimetrically in 50 mM NEM buffer
containing 0.15 M NaCl (hereafter referred to as NEM buffer) or a 60:40 (by volume) mixture of
MeOH:NEM buffer (hereafter referred to as MeOH: NEM buffer mixture) using Milli-Q water
(≥18.2 MΩ, Milli-Q integral water purification system, Millipore), to a final pH of (6.80 0r 7.25)
±

0.02. Buffer solution was chosen to ensure sufficient metal ion(II) solubility for the study

using isothermal titration calorimetry.
5.2.2 Metal ion (II) interacting with different ligands
DA2Im, NTA, BPA, TPA and Tren titration experiments with M2+ were performed in
four different solvent conditions: NEM buffer at pH (6.80 or 7.25) , MeOH: NEM buffer mixture
at pH (6.80 or 7.25) , Tris buffer at pH 7.40 or MeOH: Tris buffer mixture at pH 7.40. Some
ligands are only soluble in one solvent system and thus were not able to be studied in both
solvent systems; specifically, NTA was insoluble in MeOH: (Tris or NEM) buffer mixture, and
TPA was insoluble in NEM or Tris buffer. The NEM or Tris buffer were prepared in a 1 L
Nalgene bottle using Milli-Q water (≥18 MΩ, Milli-Q integral water purification system,
Millipore) with 0.150 M NaCl and adjusted the pH as needed. The MeOH: (Tris or NEM) buffer
mixture solvent were prepared by mixing 30 mL of MeOH with 20 mL of (NEM or Tris) buffer
in a 50 mL conical tube and the pH was readjusted to within ± 0.02 of pH 6.80 or 7.40 by adding
1 M NaOH. Solutions of each five different ligands and M2+ (M2+ = copper, cobalt, or
manganese) chloride were prepared gravimetrically and the final solution was adjusted to within
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± 0.02 units of the desired pH.
Studies of M2+ interaction with five ligands, NTA, DA2Im, TREN, TPA and BPA, were
performed with ligand as the titrant contained in the injection syringe. The reference cell was
filled with the corresponding solvent system used to prepare the M2+ and ligand solutions. The
titrant was titrated into the reaction cell in 10 μL aliquots over 20 seconds for a total of 28
injections. The syringe was set to stir at 307 rpm for the duration of the experiment. Between
each injection, 360-600 seconds elapse to ensure adequate time for the signal to return to the
baseline. A minimum of two but often three or more experiments were conducted for each ligand
to ensure reproducibility.
Table 5.1 Concentrations of Titrant and Titrate for Ligand-M 2+ Studies
Titrant
DA2Im
NTA
TREN

TPA

BPA

Titrant Concentration
(mM)
8.8
1
1.5
0.15
0.5
10
0.4
0.5
0.75
0.1
0.1
0.75
10
0.08
10
0.3
4.5
1
10

M2+

Cu2+

Co2+
Mn2+
Cu2+
Co2+
Mn2+
Cu2+
Co2+
Mn2+

Titrate (M2+) Concentration
(mM)
0.33
0.1
0.15
0.015
0.05
1
0.04

Solvent System
(buffer*)
Tris
Tris
Tris
Tris
MeOH:Tris
NEM
MeOH: NEM

0.05
0.075
0.01
0.01
0.075
0.5

MeOH: NEM
MeOH: Tris
NEM
MeOH: NEM
MeOH: NEM
Tris

6.80
7.40
6.80 and 7.25

0.004
0.5
0.03
0.3
0.05
1

NEM
MeOH: Tris
MeOH: NEM
NEM
MeOH: NEM
MeOH: NEM

6.80
7.40
6.80
6.80 and 7.25

pH

7.40

6.80 and 7.25

6.80
7.40

6.80

* Buffer Tris, MeOH:Tris, NEM, and MeOH: NEM correspond to 50 mM Tris buffer (0.150 M NaCl), 60:40 (by volume)
mixture of MeOH: 50 mM Tris buffer (0.150 M NaCl, pH 7.40), 50 mM NEM buffer (0.150 M NaCl), and 60:40 (by volume)
mixture of MeOH: 50 mM NEM buffer (0.150 M NaCl), respectively.

Data analysis was performed using Origin 7.2 software as described above. The resulting binding
isotherms were fit to an iterative, one-set-of-sites binding model or sequential binding model
(MicroCal, LLC). The binding parameters of the replicate experiments were averaged and error
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propagation was performed.
5.2.3 ML Interaction with 8-Hydroxyquinoline (8-HQ) and acetohydroxamic acid (AHA)
ITC experiments were performed to examine the interaction of AHA and 8-HQ, two
know metalloenzyme active site inhibitors, with the ML complexes (studied in Chapter 2) acting
as potential enzyme active site metal ion structural mimetics. AHA experiments were performed
in Tris buffer due to its aqueous solubility. 8-HQ was insoluble in aqueous solution and therefore
was studied in the MeOH:buffer (NEM or Tris) (60:40) mixture. Experiments with AHA were
unsuccessful because its low affinity of for the ML required the use of high AHA concentrations
which in turn was associated with large AHA dilution heat, making it impossible to extract
accurate binding parameters. Instead, UV-Vis absorbance spectroscopy was performed to obtain
binding constant.
AHA and 8-HQ solutions were prepared gravimetrically and the final solution pH was
adjusted to within ± 0.02 units of the desired pH. Each ligand and metal ion (II) solutions were
prepared gravimetrically. The solutions of the ligand and the metal ion were mixed in the
appropriate ratio to yield the desired final concentration and the final pH was adjusted to within
± 0.02 units of the desired value. For example, 1.5-mL of CuCl2 at 1 mM was mixed with 1.5 mL
of BPA at 1 mM to yield 3-mL of a Cu(BPA) complex at 0.5 mM each of Cu2+ and BPA.
ITC experiments were performed by titrating a solution of inhibitor (8-HQ or AHA) into
a solution of ML, the latter acting as an enzyme active site structural mimetic, or into a solution
of M2+. Experiments with 8-HQ were done in MeOH:(NEM or Tris) buffer mixture at pH 6.80 or
7.25 when NEM was used or at pH 7.40 when Tris was used.
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Table 5.2 Concentrations of Titrant (8-HQ) and Titrate for ML or M2+ with inhibitor.
8-HQ
Titrate
Titrate Concentration
Solvent System
pH
Concentration
(mM)
(mM)
10
2:1 BPA:Cu2+
1
MeOH:Tris
7.40
5
1:1 BPA:Cu2+
0.5
MeOH:Tris
3
1:1 BPA:Co2+
0.3
MeOH:NEM
6.80 and 7.25
10
1:1 Tren: Co2+
1
MeOH:NEM
10
1:1 TPA: Co2+
1
MeOH:NEM
10
1:1 BPA:Mn2+
1
MeOH:NEM
4
1:1 Tren:Mn2+
0.2
MeOH:NEM
6.80
10
1:1 TPA:Mn2+
1
MeOH:NEM
1
Cu2+
0.05
MeOH:Tris
7.40
10
Co2+
0.5
MeOH:NEM
7.25
2
Mn2+
0.1
MeOH:NEM
6.80
* The buffers contain 50 mM NEM or Tris, 0.150 M NaCl. The MeOH:buffer mixture corresponds to 60:40 (by volume) of
MeOH over NEM or Tris buffer. Tris was used for copper only.

Data analysis was performed using Origin 7.2 software as described above. The resulting
binding isotherms were fit with an iterative, one-set-of-sites binding model or sequential binding
model (MicroCal, LLC). The binding parameters from the replicate experiments were averaged
and error propagation was performed.

5.3. Synthesis of (N-(2-(1-methylimidazolyl)methyl)iminodiacetic acid) DA2Im
Synthesis

of

N-(2-(1-methylimidazolyl)methyl)iminodiacetic

acid

(DA2Im)

was

accomplished in two steps.99,100 Diethyl iminodiacetate (1.80 mL, 10.3 mmol) and 1-methyl-2imidazolecarboaldehyde (1.031 g, 9.4 mmol) were combined in DCE (1,2-Dichloroethane). A
reductive amination was achieved with sodium triacetoxyborohydride (2.976 g, 14.0 mmol)
under N2. The reaction was allowed to proceed overnight under stirring. The reaction was then
quenched with saturated sodium bicarbonate, extracted three times with ethyl acetate, and dried
with sodium sulfate. The product was purified by column chromatography (silica gel, 100%
ethyl acetate) to yield a light yellow oil. The oil was dissolved in 25 mL of 2 N HCl and refluxed
overnight. The product was concentrated in vacuo and dried in a vacuum oven to remove any
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residual water. Removal of solvent yielded 1.172 g of a flaky, off-white solid (38% yield). 1H
NMR (300 MHz, D2O): δ 7.25-7.32 (d, 2H), 4.2-4.4 (s, 2H), 3.8-3.9 (s, 3H), 3.6-3.8 (s, 4H). 99
In an effort to avoid generation of chlorinated waste, the synthesis was also attempted
using ethyl acetate as the solvent rather than DCE. This synthesis was unsuccessful as various
side products were generated and too difficult to purify. 99

Chapter 6: UV-Vis Spectroscopy
6.1. Methods
UV-Vis absorbance spectroscopy was used as a second method to study the interaction,
specifically, the equilibrium binding constant (Ka) for the metalloenzyme inhibitor AHA with
metal ligand binary complexes (ML).
6.2. Formulae for Calculating Ka
In light of the poor ITC data, and therefore inconclusive results, for acetohydroxamic
acid (AHA) as an inhibitor (I) binding to the Cu2+L (CuL) complexes, we turned to UV-Vis
absorbance spectroscopy to determine the binding constant, Ka. The equilibrium between the
binary complex ML, the inhibitor (I) and the ternary complex MLI is shown below
ML + I ⇌ MLI

(Equation 6.1)

The equilibrium constant, Ka, can be expressed as follows:
K𝑎 =

[MLI]

(Equation 6.2)

[ML][I]

To determine the equilibrium concentrations of the reactants and the products needed for the
calculation of Ka, UV-Vis absorbance spectra were recorded for the following samples: 1) the
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ML binary complex (formed at 1:1 molar ratio of M:L); 2) the MLI ternary complex (formed at
1:1:300 molar ratio of M:L:I); 3) a mixture of ML and MLI complexes (formed at 1:1:1 molar
ratio of M:L:I). At the concentrations of M and L used ( [M] = [L]; 0.5 mM for all but 1 mM
when L was TREN), a 1:1 M:L mixture consisted predominantly of the ML binary complex; a
mixture of M, L and I at the 1:1:300 molar ratio consisted predominantly of the MLI ternary
complex; a mixture of a M, L and I at 1:1:1 molar ratio consisted of both ML and MLI.
To derive an equation for calculating the Ka, the Beer’s Law (6.3 Equation) relating absorbance
(A) to concentration (c) of the absorbing molecule was used.
𝐴 = 𝜀𝑏𝑐

(Equation 6.3)

where ε is the molar absorption coefficient (M-1cm-1); b is the length of the path traversed by the
light (which is 1 cm for all samples).
Assuming that C◦ is the initial concentration of ML before the addition of I. to a final
molar ratio of 1:1:1 (M:L:I) which moves the equilibrium to the product side. Assuming the new
equilibrium concentration of ML to be x, the equilibrium concentration of I and MLI would be x
and C0 – x, respectively.
Table 6.1 The concentration of each product and reactant in the equilibrium reaction.

Initial concentration (1:1:1 M:L:I)
Changes after reaching equilibrium upon

ML

I

MLI

C0

C0

0

x - C0

x - C0

C0 -x

x

x

C0 -x

addition of I to ML binary complex
Equilibrium concentration

At a given wavelength, the absorbance of ML (formed at 1:1 molar ratio of M:L) is
labeled as A-1; the absorbance of MLI (formed at the molar ratio of 1:1:300 of M:L:I) is labeled
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as A; the absorbance of the mixture of ML and MLI formed at the molar ratio of 1:1:1 of M:L:I
is labeled as A0. According to the Beer’s Law, the following equations can be written for the ML
and the MLI complexes:
𝐴 −1 (1: 1) = ℇ−1 𝑏 C◦

(Equation 6.4a)

𝐴

−1
ℇ−1 = 𝑏 .𝐶∘

(Equation 6.4b)

𝐴 (1: 1: 300) = ℇ 𝑏 C◦

(Equation 6.5a)

𝐴

ℇ = 𝑏 .𝐶∘

(Equation 6.5b)

𝐴° (1:1:1) = -1bx +  b ( C° - x)

(Equation 6.6)

𝐴° (1: 1: 1) = ℇ°𝑏𝐶 = ℇ−1 𝑏𝑥 + ℇ𝑏(C° − 𝑥)

(Equation 6.7)

(Equation 6.7) is the absorbance for the mixture of ML and MLI formed upon addition of one
molar equivalent of I into the ML (i.e., 1:1:1 M:L:I). It is based on the principle that the
absorbance of a mixture at any wavelength is equal to the sum of the absorbance of each
component at that wavelength.
By substituting -1 and  in (Equation 6.7) with the expressions in (Equation 6.4b and 6.5b), the
following equation for A0 is obtained
𝐴∘ =

𝐴 −1
𝑏 𝐶∘

𝐴

𝑏𝑥 + 𝑏 𝐶∘ 𝑏(𝐶 ∘ −𝑥) =

𝐴 −1
𝐶∘

𝐴

𝑥 + 𝐶∘ (𝐶 ∘ −𝑥) =

(Equation 6.8)
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𝐴 −1
𝐶∘

𝐴

𝑥 + 𝐴 − 𝐶∘ 𝑥 =

𝐴 −1 −𝐴
𝐶∘

𝑥+𝐴

𝐴 ∘ −𝐴 =

𝐴 −1 −𝐴
𝐶∘

𝑥

𝐴∘− 𝐴

Therefore, 𝑥 = 𝐴

−1 −𝐴

(Equation 6.9)

𝐶∘

(Equation 6.10)

where the value Aₒ is the absorbance observed when a molar equivalent of I was added to the
binary complex ML formed at 1:1 molar ratio of M:L. This absorbance is the total absorbance of
the ML and MLI present;
Substituting the expression of x into the equation for Ka, we have the following:
𝐾𝑎 =

=

𝐶∘ −𝑋
𝑋𝑋

=

(𝐴∘− 𝐴 −1 )
(𝐴− 𝐴∘)2 𝐶∘

𝐴∘− 𝐴
𝐶∘
𝐴 −1 −𝐴
𝐴∘− 𝐴 2
(
) 𝐶∘2
𝐴 −1 −𝐴

𝐶∘ −

(𝐴 − 𝐴 −1 ) =

=

𝐴− 𝐴∘
)
𝐴−𝐴 −1
𝐴− 𝐴∘ 2
(
) 𝐶∘2
𝐴−𝐴 −1

𝐶∘ (1−

=

(𝐴 −1 − 𝐴∘) (𝐴 −1 − 𝐴)
(𝐴− 𝐴∘)2 𝐶∘

(
(

𝐴∘− 𝐴 −1
)
𝐴−𝐴 −1
𝐴− 𝐴∘ 2

𝐴−𝐴 −1

) 𝐶∘

(Equation 6.11)

(Equation 6.12)

Equation 6.12 was used to calculate the binding constant Ka of AHA for each of the five CuL
binary complexes.
UV-Vis absorbance experiments for DA2Im and NTA were performed in the Tris buffer but not
MeOH:Tris buffer as the two ligands are not soluble in the presence of MeOH. Experiments for
TREN was performed in the Tris buffer only and BPA was performed in both solvent systems.
Experiments for TPA were performed in MeOH:Tris buffer mixture only as it was not soluble in
buffer alone.
Three wavelengths were chosen within the spectral region that yielded the most absorbance
difference between the ML and MLI (M= Cu2+ , I=AHA, and L= DA2Im, NTA, TREN, BPA, or
TPA). The absorbance difference at each of the three wavelengths were used to calculate the Ka
using (Equation 6.12) and the resulting three Ka values were averaged. It should be noted that
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none of the five ligands studied showed absorbance within the chosen region of wavelength.
Analysis of the data was performed using Origin Lab software.

6.2. Results and Discussion
6.2.1 UV-Vis spectra for CuL interaction with AHA
Due to the weak affinity of AHA for CuL binary complexes, its interaction was not able
to be determined accurately using ITC. Instead, UV-Vis spectroscopy was used to examine this
interaction. As explained in section 6.1.1, absorbance readings of three samples of a CuL
complex with and without AHA were prepared and their absorbance spectra were recorded.
Specifically, the samples include the CuL binary complex, a 1:1:1 (Cu2+:L:AHA) molar ratio
mixture and a 1:1:300 (Cu:L:AHA) molar ratio mixture. The 1:1:300 sample corresponded to
CuL(AHA) which corresponded to all CuL complexes fully bound with AHA, the binding
constant of AHA for CuL was calculated using absorbance readings at several wavelengths. All
the reading was taken after the baseline correction at lab temperature.
In general, the absorbance of the CuL binary complex at the chosen wavelengths
decreased with the addition of AHA except for Cu(TREN) for which absorbance increased upon
addition of AHA. For Ka calculation, three wavelengths were chosen within a spectral region
chosen for the highest absorbance difference between CuL and CuL(AHA) and the lowest or no
absorbance from Cu2+ and the ligand alone. The range of the wavelength thus selected for all
ligands was 280-400 nm. The binding constant (Ka) of AHA for each of the CuL complexes were
on the order of 101–102 M-1 (Table 4.2),
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Table 6.2 Binding affinity of CuL binary complex with AHA as derived from UV-Vis
absorbance spectroscopy.
ML

C◦(𝐌)

Solvent

(3.3 ± 0.2) ×102

Cu(DA2Im)
Cu(NTA)
Cu(TREN)
Cu(BPA)
Cu(BPA)
Cu(TPA)

Ka (M-1)

Tris buffer

(2.49 ± 0.07) ×102

MeOH:Tris buffer

(2.8 ± 0.0) ×101
(2.6 ± 0.32) ×102
(4.1 ± 0.61) ×102
(2.3 ± 0.4) ×102

0.500 ×10-3
1.00 × 10-3

*UV-Vis absorbance readings were taken after adding 0.3 (g) AHA. A standard deviations of one-sigma error bars
were used form the average of three measurements.

The experiments were done in Tris buffer and/or MeOH:Tris buffer mixture depending
on the solubility of the ligand. Data for Cu(DA2Im) and Cu(NTA) were obtained in Tris buffer
only while data for Cu(TPA) were obtained in MeOH:Tris buffer only.
Cu(NTA) and Cu(DA2Im) were found to bind AHA with slightly different affinity, with
Ka being (2.49 ± 0.07) × 102 M-1 for Cu(NTA) and (3.3 ± 0.2) × 102 M-1 for Cu(DA2Im).
DA2Im and NTA differ only in the fourth coordinating atom which was a carboxyl oxygen in
NTA but an imidazole nitrogen in DA2Im. An imidazole nitrogen in general binds metal ions
more strongly than a carboxyl oxygen, which would predict Cu(DA2Im) to have a weaker
affinity for an additional ligand, AHA in this case. However, the additional negative charge on
the 3rd carboxyl of NTA would likely exert a repulsive effect on the deprotonated AHA. These
two opposing effects seemed to have mostly cancelled out, resulting in only slightly different
affinity for the two ML complexes for AHA.
The affinity of Cu(TREN) for AHA in Tris buffer was found to be an order of magnitude weaker
than that of Cu(DA2Im) and Cu(NTA). This was clearly due to the stronger affinity of Cu2+ for
TREN than for DA2Im and NTA (Figs. 6.1 , 6.2, and 6.3).
Between Cu(TPA) and Cu(BPA), Cu(BPA) bound AHA approximately twice more strongly than
105

Cu(TPA) did. Again, this was consistent with TPA, a tetradentate ligand, binding Cu2+
significantly more strongly than BPA, a tridentate ligand that shares three identical coordination
groups with TPA.
Although the presence of methanol had an effect on the affinity of Cu(TREN) for AHA, it did
not alter the affinity of Cu(BPA) for AHA. This was consistent with the pyridyl nitrogens in
BPA being fully deprotonated in either the buffer or the MeOH:buffer mixture prior to metal
binding, therefore experiencing no effect on the difference in proton competition in the presence
and absence of methanol.
In summary, the affinity constant obtained from the UV-Vis method of AHA for the five CuL
binary complexes followed a trend that was consistent with the relative affinity of the five
ligands for Cu2+ as determined in the ITC experiments in Chapter 3.

1.0

Cu:DA2Im (1:1)
Cu:DA2Im:AHA (1:1:1)
Cu:DA2Im:AHA (1:1:300)
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Figure 6.1 UV-Vis spectra of Cu:DA2Im:AHA in Tris buffer at pH 7.40 with Cu2+:DA2Im at 0.5 mM and AHA at
1 and 300 mM. The spectrum in black was for Cu:DA2Im (1:1), the one in red was for Cu:DA2Im:AHA (1:1:1), and
the one in blue was for Cu:DA2Im:AHA with the additional of 300 mg of AHA. The chosen wavelengths are 290,
295, and 300 nm. A standard deviations of one-sigma error bars were used form the average of three measurements.
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Cu:NTA (1:1)
Cu:NTA:AHA (1:1:1)
Cu:NTA:AHA (1:1:300)
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Figure 6.2 UV-Vis spectra of Cu:NTA:AHA in Tris buffer at pH 7.40 with Cu2+:NTA at 0.5 mM and AHA at 1 and
300 mM. Spectrum in black shows the absorbance of Cu:NTA, spectrum in red shows the absorbance of
Cu:NTA:AHA (1:1:1), and the spectrum blue shows the absorbance of Cu:NTA:AHA with the additional of 300 mg
of AHA. The chosen wavelengths were 285, 290, and 295 nm. A standard deviations of one-sigma error bars were
used form the average of three measurements.
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Figure 6.3 UV-Vis spectra of Cu:TREN:AHA into Tris buffer at pH 7.40 with Cu2+:TREN at 0.5 mM and AHA at 1
and 300 mM. Spectrum in black shows the absorbance of Cu:TREN, the spectrum in red shows the absorbance of
Cu:TREN:AHA (1:1:1), and the spectrum in blue shows the absorbance of Cu:TREN:AHA with the additional 300
mg of AHA. The chosen wavelengths were 380, 390, and 400 nm. A standard deviations of one-sigma error bars
were used form the average of three measurements.

107

1.0

Cu:BPA (1:1)
Cu:BPA:AHA (1:1:1)
Cu:BPA:AHA (1:1:300)

Abs

0.8

0.6

0.4

0.2
280

285

290

295

300

Wavelength (nm)

Figure 6.4 UV-Vis spectra of Cu:BPA:AHA into Tris buffer at pH 7.40 with Cu2+:BPA at 0.5 mM and AHA at 1
and 300 mM. Spectrum in black shows the absorbance of Cu:BPA, the spectrum in red shows the absorbance of
Cu:BPA:AHA (1:1:1), and the spectrum in blue shows the absorbance of Cu:BPA:AHA with the additional 300 mg
of AHA. The chosen wavelengths were 285, 290, and 295 nm. A standard deviations of one-sigma error bars were
used form the average of three measurements.
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Figure 6.6 UV-Vis spectra of Cu:BPA:AHA into MeOH:Tris buffer at pH 7.40 with Cu2+:BPA at 0.5 mM and AHA
at 1 and 300 mM. Spectrum in black shows the absorbance of Cu:BPA, the spectrum in red shows the absorbance of
Cu:BPA:AHA (1:1:1), and the spectrum in blue shows the absorbance of Cu:BPA:AHA with the additional 300 mg
of AHA. The chosen wavelengths were 285, 290, and 295 nm. A standard deviations of one-sigma error bars were
used form the average of three measurements.
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Cu:TPA (1:1)
Cu:TPA:AHA (1:1:1)
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Figure 6.7 UV-Vis spectra of Cu:TPA:AHA into MeOH:Tris buffer at pH 7.40 with Cu2+:TPA at 1 mM and AHA
at 1 and 300 mM. Spectrum in black shows the absorbance of Cu:TPA, the spectrum in red shows the absorbance of
Cu:TPA:AHA (1:1:1), and the spectrum in blue shows the absorbance of Cu:TPA:AHA with the additional 300 mg
of AHA. The chosen wavelengths were 305, 315, and 325 nm. A standard deviations of one-sigma error bars were
used form the average of three measurements.

Chapter 7: Computational Methods
7. Computational Studies of enzyme active site metal ion structural mimetics with
metalloenzyme inhibitors
7.1. Computational Methods
There has been growing interest in transition metals (TM) and their complexes in
computational chemistry, not only because of the very important roles these elements play in
modern chemistry, but also due to the known difficulties associated with their theoretical
treatments. The biggest problem associated with the calculation of TM-containing systems is the
near degeneracy stemming from electrons partially occupying the d orbitals. Recently, several
studies have been conducted to evaluate the performance of different density functional theory
(DFT) methods for predicting several molecular properties and studying reactions involving
TMs. Additionally, several studies have been carried out to improve the performance of DFT
methods. However, in order to obtain very accurate and reliable calculations for the TM109

containing systems, one must implement multi-reference methods such as Multi-Reference
Configuration Interaction (MRCI). Unfortunately, these kinds of methods are usually very
expensive to run. Therefore, as the interest in carrying out calculations for large systems (such as
proteins) keeps growing, it becomes increasingly desirable to identify computational methods
that are less expensive than multi-reference methods but still able to achieve good performance.
DFT is a promising choice because it is able to efficiently predict the atomic and molecular
properties for a variety of systems. DFT has great advantage over the Hartree-Fock (HF) method
in describing electron correlation effects and has favorable scaling properties with respect to
molecular size when compared to post-Hartree-Fock methods. As a result, DFT is a widely used
computational approach for studying large TM-containing compounds and shows significant
promise as an ab initio method that can be used to investigate large macromolecules such as
proteins and DNA.101
In this study, ab initio calculations were performed for the interactions of Cu2+ with
ligands and CuL binary complexes with 8-HQ using the Gaussian 2009 program package.102All
geometry optimizations, frequency calculations, and BSSE-corrected complexation energy
calculations were conducted at the HF/3-21g and BLYP/ CC-pVDZ levels of theory.
Complexation energies were calculated by subtracting the individually optimized and calculated
energies of the CuL complex and inhibitors from the energy of the optimized complex. Basis set
effects were explored using the larger cc-PVDZ basis set.
First, we examined the total energy for all five ligands. Second, we determined the
binding affinity of the binary complexes by subtracting the total energy of the ligand and the
metal ion (Cu2+ or Zn2+) from the total energy of the binary complexes. Finally, we obtained the
binding affinity of the inhibitor 8-HQ for the binary complexes. All calculations were done by
using HF/ 3-21G or BLYP/ CC-pVDZ basis set and the geometry was shown in the Figures
bellow.
7.2 Optimized structure of individual compound
Computational studies of copper ion (II), zinc ion (II), and all five ligands were
performed by using two different calculations with two different basis sets: HF/3-21G and
BLYP/ CC-pVDZ (Figure 7.1-7.5). All these compounds were optimized and their energies were
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determined (Table 7.1). Structural optimization of the ligand and the metal ion allows more
accurate estimation of the energy state. The computational data concludes that using larger basis
sets allow more accurate the compound more stable, i.e. the energy is more negative.

Figure 7.1 Optimized structure of the inhibitor AHA as calculated in gas phase via HF level of
theory with a 3-21G basis set.

Figure 7.2 Optimized structure of the inhibitor 8-HQ as calculated in gas phase via BLYP level
of theory with a 3-21G basis set.
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Figure 7.3 Optimized structure of the ligand NTA as calculated in gas phase via HF level of
theory with a 3-21G basis set.

Figure 7.4 Optimized structure of TREN as calculated in gas phase via BLYP level of theory
with a CC-pVDZ basis set.
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Figure 7.5 Optimized structure of the ligand TPA as calculated in gas phase via HF level of
theory with a 3-21G basis set.

Table 7.1 Total energy and the basis set used for the metal ions, inhibitors, and ligands.

Metal Ions
Cu2+
Cu2+
Zn2+
Zn2+
Inhibitors
AHA
8-HQ
8-HQ
8-HQ
Ligands
TPA
DA2Im
NTA
BPA
TREN

Basis Set
HF/3-21G
BLYP/ CC-pVDZ
HF/3-21G
BLYP/ CC-pVDZ

Total Energy (kcal/mol)
-2.05 × 106
-2.06 × 106
-1.11 × 106
-1.12 × 106

HF/3-21G
HF/3-21G
BLYP/3-21G.
BLYP/ CC-pVDZ

-1.76 × 105
-2.96 × 105
-2.98 × 105
-2.99 × 105

HF/ 3-21G
HF/ 3-21G
HF/3-21G.
BLYP/ CC-pVDZ
BLYP/ CC-pVDZ

-5.68 × 105
-5.06 × 105
-4.59 × 105
-3.95 × 105
-2.87 × 105
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7.3 Optimized structure of MI, ML, and ML2 complexes
Computational studies of copper (II) complexes with the five ligands and the inhibitor 8HQ, and zinc (II) complexes with TPA and BPA were performed by using two different
calculations with different basis sets: HF/3-21G and BLYP/ CC-pVDZ. The structures of the
compounds were optimized (Figures 7.6-7.15) and the calculated Gibbs free energies for each
species are listed (Tables 7.1 and 7.2). The binding energies, i.e., the Gibbs free energies for the
formation of the binary (ML) and the tertiary complexes (MLI), are calculated by subtracting the
energies of the reactants from the energy of the binary or ternary complex (Table 7.2). The
computational data concludes that using the larger basis set (BLYP), which better approximates
the wave function, yielded more negative binding energy thus more stable complexes.
The binding energies for Cu(DA2Im) and Zn(TPA) were found to be positive, indicating
that these complexes were unstable in the gas phase. The rest of the binary complexes studied
include Cu(NTA), Cu(TREN), Cu(BPA), Cu(TPA), Cu(8-HQ) and Zn(BPA) and they were
found to be stable in the gas phase. The ternary complexes studied include Cu(8-HQ)2,
Cu(DA2Im)2 and Cu(BPA)2 and they were also stable (Table 7.2). Other isomers for Cu(8-HQ)2
may be more stable and more work is needed.
Formation of the Cu(DA2Im)2 complex had a negative energy, suggesting that adding a
second DA2Im to Cu(DA2Im) helped stabilize the complex. Similarly, adding a second BPA to
Cu(BPA) made it slightly more stable. In addition, Cu(BPA) was more stable than Zn(BPA).
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Also, Cu(NTA) was more stable than Cu(DA2Im). Cu(TREN) binary complex was the most
stable complex out of the five CuLcomplexes.
Some of the trends in binding energy detailed above were consistent with the trend
observed in solution that was determined using ITC. For example, DA2Im and BPA both formed
CuL and CuL2 complexes in solution, consistent with the findings as calculated in the gas phase
that adding a second L stabilized the complex. In other cases, the trend observed in gas phase did
not agree with the trend obtained in solution. For example, in solution, DA2Im bound Cu2+ more
strongly than NTA did. However, in gas phase, Cu(NTA) was stable while Cu(DA2Im) was not.
To conclude, the low basis set and the gas phase used for the computational study indicate that
the values obtained in computational study cannot be directly correlated with the ITC data in
solution. Further calculations will need to be carried out by using solvation models to better
mimic ion or group solvation and protonation state in order to provide a better comparison to
results from the ITC studies.

Figure 7.6 Optimized structure of 8-HQ-Cu2+ binary complex. The complex calculated in gas
phase via BLYP level of theory with a CC-pVDZ basis set.
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Figure 7.7 Optimized structure of 8-HQ-Cu2+ binary complex. The complex calculated in gas
phase via BLYP level of theory with a 3-21G basis set.

Figure 7.8 Optimized structure of 8-HQ-Cu2+-8-HQ complex. The complex calculated in gas
phase via BLYP level of theory with a CC-pVDZ basis set.
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Figure 7.9 Optimized structure of Cu2+-DA2Im complex. The complex calculated in gas phase
via HF level of theory with a 3-21G basis set.

Figure 7.10 Optimized structure of NTA-Cu2+ binary complex was calculated in gas phase via
HF level of theory with a 3-21G basis set.

117

Figure 7.11 Optimized structure of TREN-Cu2+. The binary complex was calculated in gas
phase via HF level of theory with a 3-21G basis set.

Figure 7.12 Optimized structure of TPA-Cu2+ binary complex. The binary complex was
calculated in gas phase via (HF or BLYP) level of theory with a (3-21G or CC-pVDZ) basis
set, respectively.
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Figure 7.13 Optimized structure of BPA-Cu2+ binary complex. The complex calculated in gas
phase via BLYP level of theory with a CC-pVDZ basis set.

Figure 7.14 Optimized structure (not completed) of BPA-Cu2+-BPA complex. The complex
calculated in gas phase via BLYP level of theory with a CC-pVDZ basis set.

Figure 7.15 Optimized structure of BPA-Zn2+ binary complex. The complex calculated in gas
phase via BLYP level of theory with a 3-21G basis set.
Table 7.2 Total and binding energies for binary or ternary complexes
Complexes

Basis Set

Total Energy
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Binding Energy

DA2Im-Cu2+-DA2Im

BLYP/ CC-pVDZ
BLYP/ CC-pVDZ
HF/3-21G.
HF/3-21G.

(kcal/mol)
1.33 × 106
1.63 × 106
1.53 × 106
2.03 × 106

(kcal/mol)
-1.03 × 106
-1.03 × 106
1.09× 103
-4.91 × 103

NTA-Cu2+
TREN-Cu2+
TPA-Cu2+
TPA-Cu2+
TPA-Zn2+
BPA-Cu2+
BPA-Cu2+-BPA
BPA-Zn2+

HF/3-21G.
HF/3-21G
HF/3-21G
BLYP/ CC-pVDZ
HF/3-21G
BLYP/ CC-pVDZ
BLYP/ CC-pVDZ
BLYP/ CC-pVDZ

1.48 × 106
1.32 × 106
1.59 × 106
1.60 × 106
1.68 × 106
1.42 × 106
1.80 × 106
1.51 × 106

-1.91 × 103
-1.03 × 106
-9.12 × 102
-1.03 × 106
1.88 × 103
-1.04 × 106
-1.05 × 106
-9.17 × 104

8-HQ-Cu2+
8-HQ-Cu2+-8-HQ
DA2Im-Cu2+

Table 7.3 Bond lengths of the optimized structure of Cu2+-8-HQ, Cu2+-(8-HQ)2, Cu2+-BPA,
Cu2+-(BPA)2, and Zn2+-BPA using different basis set.
Basis Set
BLYP/ 3-21G
BLYP/ CC-pVDZ
BLYP/ CC-pVDZ

BLYP/ CC-pVDZ
BLYP/ CC-pVDZ
BLYP/ CC-pVDZ.

Complex
Cu2+-8-HQ
Cu2+-8-HQ
Cu2+-(8HQ)2
2+

Cu -BPA
Zn2+-BPA
Cu2+-(BPA)2

N1-Cu
1.77
2.01
2.05

O1-Cu
1.73
2.01
1.97

Bond Lengths (Å)
N2-Cu
O2-Cu
2.05
1.97

-

-

N1-Cu2+
2.28
2.10
3.25

N2-Cu2+
1.94
1.96
2.43

N3-Cu2+
1.94
1.96
1.86

N5-Cu2+
2.00

N6-Cu2+
1.94

N4-Cu2+
3.33

The bond lengths obtained for CuL and CuL2 complexes for other ligands are listed in
(Table 7.4). The data indicate that using different basis set yielded different bond lengths thus
binding energy and results from the higher basis set are expected to be more accurate.
Comparing bond lengths for Cu(8-HQ) to that of Cu(8-HQ)2 obtained using the higher basis set
indicate that the two 8-HQ molecules have identical coordination bond lengths suggesting
identical binding affinity. This was consistent with the ITC result that the two 8-HQ bound Cu2+
with the same Ka value. In contrast, comparing the bond lengths of Cu(BPA) to Cu(BPA)2, it was
clear that the second BPA had longer coordination bond lengths than the first BPA, suggesting
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that the second BPA bound Cu2+ with weaker affinity. This was indeed confirmed by the ITC
data.
7.4 Optimized structure of MLI complex
Calculations were performed on the interaction between Cu(BPA) and Zn(BPA)
compounds with 8-HQ (Table 7.4). All of these compounds were optimized and their binding
energies were determined. The computational data concludes that using larger basis set yields a
more negative binding energy, i.e., more stable compound.

Figure 7.16 optimized structure of Cu(BPA)(8-HQ) ternary complex. The complex calculated in
gas phase via BLYP level of theory with a 3-21G basis set.

Figure 7.17 Optimized structure of Cu(BPA)(8-HQ) ternary complex. The complex calculated in
gas phase via BLYP level of theory with a CC-pVDZ basis set.
121

Figure 7.18 Optimized structure of Zn(BPA)(8-HQ) ternary complex. The complex calculated in
gas phase via BLYP level of theory with a 3-21G basis set.

Figure 7.19 Optimized structure (not completed) of Zn(BPA)(8-HQ) ternary complex. The
complex calculated in gas phase via BLYP level of theory with a CC-pVDZ basis set.
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Table 7.4. Bond lengths and binding energy of Cu(BPA)(8-HQ) and Zn(BPA)(8-HQ) using
different basis set.
Basis Set

BLYP/321G

Complex

Cu(BPA)(8HQ)

BLYP/CCpVDZ
BLYP/321G
BLYP/CCpVDZ

Bond Lengths (Å)

Binding Energy
(kcal/mol)

N1M2+
2.01

N2-M2+ N3-M2+ N4-M2+ O1-M2+
1.94

1.94

1.99

1.92

-7.51 × 103

2.15

2.07

2.13

2.26

1.97

1.32 × 103

2.20

1.98

1.98

1.95

1.96

3.01 × 106

2.26

2.19

2.20

2.11

1.97

9.17 × 103

Zn(BPA)(8HQ)

*Numbers correspond to numbering in Figure 7.(18, 19, 20, and 21)

Figure 7.20 Optimized structure of the BSSE correction optimized structure of Zn(BPA)(8-HQ)
ternary complex. The complexes shown were calculated in gas phase via BLYP level of theory
with a CC-pVDZ basis set.
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Figure 7.21 Optimized structure of the BSSE correction of Cu(BPA)(8-HQ) ternary complex.
The complexes shown were calculated in gas phase via BLYP level of theory with a CC-pVDZ
basis set.
Table 7.5 Total Energies of BSSE correction optimized structure of BPA-Zn2+-8-HQ and BPACu2+-8-HQ ternary complex. The complexes shown were calculated in gas phase via BLYP level
of theory with a CC-pVDZ basis set.
complex

Binding Energy (kcal/mol)

Zn(BPA)(8-HQ)

-1.50 × 106

Cu(BPA)(8-HQ)

-1.42 × 106
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